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This thesis describes the synthetic, structural and catalytic studies of Ru(II) 
and Ni(II) N,S-heterocyclic carbene complexes. It will be organized into six 
chapters.  
1) Chapter 1 is a literature review of metal carbene chemistry. The first part of 
this chapter is a description of the development of NHC chemistry and NSHC 
chemistry in particular. The second part is the introduction of recent progress 
in Ru-NHC chemistry. 
2) A series of ruthenium(II) N,S-heterocyclic carbene (NSHC) complexes 
RuIIX(RCOO)(PPh3)2(3-R’BzTh) (2.1–2.6) has been synthesized and 
characterized. They represent the first isolation of Ru-NHC complexes of 
benzothiazol-2-ylidene kind. Their catalytic activities towards transfer 
hydrogenation of ketones have been examined and discussed. 
3) Phosphine exchange of RuIIBr(MeCOO)(3-RBzTh)(PPh3)2 (2.1) (3-RBzTh 
= 3-benzylbenzothiazol-2-ylidene) with dppm, dppv, dppf, dppb and dppp 
gives mononuclear and neutral octahedral complexes 
RuBr(MeCOO)(3-RBzTh)(η2-P2) (P2 = dppm (3.1), dppv (3.2), dppf (3.3), 
dppb (3.4), dppp (3.5)). The structures of these products show two structural 
types depending on the relative dispositions of the ligands. Two geometric 
isomers of 3.5 (3.5a and 3.5b) have been isolated. The kinetic product 3.5b 
eventually converts to 3.5a upon standing. These complexes are also active 
ii 
towards transfer hydrogenation. 
4) A series of olefin-tethered N,S-heterocyclic Ru(II) complexes (4.1–4.4) has 
been synthesized and characterized by X-ray single-crystal diffraction studies. 
The different coordination environments of ruthenium centre are caused by 
tuning the steric properties of olefin group on nitrogen arm. These complexes 
with unique combinations of olefin and NSHC carbene ligands are active 
towards transfer hydrosilylation. 
5) The influence of acid or base on Ru-NSHC (2.1 and 2.2) has also been 
discussed. The former study provided a simple way to synthesize solvento 
(acetonitrile) Ru(II)-NSHC complexes in avoiding using silver source. The 
latter study describes intramolecular sp2 and sp3 C-H bond activation in 
Ru(II)-NSHC complexes. They represent the first examples of Ru(II)-NSHC 
complexes with C-H activation and mixed NNHC and NSHC Ru(II) 
complexes.  
6) A series of square-planar N,S-heterocyclic carbene (NSHC) complexes 
trans-[NiX2(N-RBzTh)2] (BzTh = benzothiazolin-2-ylidene) (6.1–6.5) has 
been synthesized and characterized by X-ray single-crystal diffraction analysis. 
These are the first crystallographically established NSHC complexes in the 
literature. The N,S-heterocyclic carbene (NSHC) rings invariably twist away 
from coplanarity with the metal coordination plane such that the N-substituent 
moves on top and below the metal to facilitate electrostatic γ-hydride 
interaction thus giving an essentially [4+2] coordination at the Ni(II) center. 
iii 
These compounds are active toward reductive Ullmann-type coupling 
reactions in Bu4NBr showing higher activities towards bromoanisole or 
bromotoluene than bromobenzene. 
iv 
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Chapter 1 Introduction 
 
1.1 N,S-Heterocyclic Carbene Chemistry 
1.1.1 Brief History of Carbenes 
A carbene is an organic species with six valence electrons and a regular 
formula is RR’C:.1 The concept of carbene could be dated back to early 1903 
by Eduard Buchner in cyclopropanation studies of ethyl diazolacetate with 
toluene.2 Later on, Hermann Staudinger proposed methylene (i.e., prototypical 
carbene H2C:) intermediate in converting alkenes to cyclopropanes in the 
presence of diazomethane in 1912.3 Another common reactive carbene 
intermediate is dichlorocarbene (dichloromethylidene, Cl2C:) which was first 
trapped by Doering in 1954.4  
For quite a long time, carbenes are known as unstable and short-lived 
species and can only be studied by the reaction undergoing without isolation. 
In spite of that, persistent carbenes were postulated by Breslow in 1957.5-6 
Then Wanzlick and collaborators speculated that the carbene existed in an 
unfavorable equilibrium with its corresponding dimer in 1960 and they 
successfully reported the first examples of introducing the stable carbenes 
coordinated to metal center in 1968.7,8 Surprisingly, the pursuit of persistent 
carbene was dormant for about 20 years before the first stable and crystalline 
carbene was isolated by the Arduengo group in 1991.7 (Scheme 1.1) The stable 
carbenes represent a milestone in N-heterocyclic carbene chemistry. Since 
2 
then, a plethora of stable N-heterocyclic carbenes were reported and their 
corresponding chemistry was thus deeply explored. 
 
 
Scheme 1.1 Isolation of the first stable N-heterocyclic carbene 
 
1.1.2 Classes of NHCs 
N-heterocyclic carbenes as the name implies are the cyclic carbenes with at 
least one amino substituent. Numerous subclasses of NHCs have emerged 
since the isolation of the first free imidazol-2-ylidene carbene.7 To date, the 
imidazol(in)-2-ylidene carbenes are among the most stable and well studied 
subclass.8 Meanwhile, triazol-5-ylidene carbenes, another family of NHCs 
firstly developed by Enders’ group,9 are catching up with 
imidazol(in)-2-ylidene carbenes. In addition, the abnormal/remote carbenes 
are recently found to be attractive.10-17 These carbenes may be coordinated to 
metals by C4/C5 of imidazolium-derived ligands, or be the ligands from 
pyridylidene family, prazoylium, quinolinium and indolium salts and are thus 
not conventional Arduengo-type carbenes. Besides these abnormal/remote 
carbenes, the attempts to replace one nitrogen atom in NHCs with other 
heteroatoms (O or S) also appeared. However, due to their instability 
mentioned above, N,S-heterocyclic (NSHC) or N,O-heterocyclic (NOHC) 
3 
chemistry are less developed.18-19 The following section will focus on the 
development of N,S-heterocyclic (NSHC) carbenes. 
1.1.3 Advantages of NHCs 
The main driven force in the success story of NHCs is their superior properties 
as ligands in catalytic processes triggered by Herrmann’s20 and Grubbs’ 
work21. Back in 1993, Herrmann reported that NHCs were congeners of 
phosphanes with regard to their metal-coordination chemistry.22 They were 
also considered as better donors than phosphine ligands by Nolan et al.23 Thus, 
most metal-NHC complexes were prepared from metal-phosphine complexes 
by simple substitution of phosphines with NHCs. Although NHCs are mimics 
of phosphines, they could compensate for the drawbacks of phosphines such 
as air sensitivity, high toxicity and unpleasant odours. Notable examples 
include Grubbs’ second generation catalysts and Pd-catalyzed coupling 
reactions.24-31 In addition, NHCs exhibit versatile steric topography by 
introduction of ancillary ligands which make them ideal candidates for various 
organic reactions. More specifically, NHCs would gradually surpass the 
ubiquitous phosphanes as ligands in a number of organometallic catalytic 
reactions. 
1.1.4 General Introduction of N,S-Heterocyclic Carbene (NSHC) 
The N,S-heterocyclic carbene, i.e., thiazole-derived carbene shares similar 
chemical behavior with N,N-heterocyclic carbene, but with notable structural 
difference which is the replacement of one nitrogen atom and its substituent 
4 
with a sulfur center. This large sulfur atom breaks the stable geometry of the 
imidazole-2-ylidenes. Furthermore, it may diminish pπ-pπ interactions 
between the carbene center and the neighboring heteroatoms (nitrogen and 
sulfur atoms). Additionally, this larger sulfur atom bears no exocyclic 
substituent to stabilize the carbene center at the 2-position. Thus, the 
thiazole-derived carbene is understandably easier to dimerize or react with 











One of the early prominent examples bearing N,S-heterocyclic carbene 
skeleton is thiamine (1.1), a moiety of Vitamin B1, whose structure contains a 
pyrimidine ring and a thiazole ring linked by a methylene bridge. The 
thiamine has been proved to be the coenzyme for several important 
biochemical reactions. Breslow demonstrated the mechanism for the benzoin 
condensation reaction catalyzed by thiamine in 1958,32 which proceeded via 
the zwitterions of thiazolium salts of thiamine pyrophosphate followed by 
deprotonation on 2-position of the thiazolium ring. The thiazole-derived 
carbenes were then explored as organocatalysts for a number of reactions.33-35 
At that time, there were a few examples of transition metal complexes based 
5 
on N,S-heterocyclic carbene ligands.36-39 Although considerable chemistry has 
been carried out using thiazole-derived carbene as intermediates, none of these 
carbenes was obtained and characterized as stable species until 1997 by 
Arduengo.40 (Scheme 1.2) A notable problem in the use of free-carbene as 
precursor is its instability and tendency towards dimerisation in the presence 
of a protic acid. Thus, the isolation of free N,S-heterocyclic carbene is 
particularly promising as it promotes one’s understanding towards a series of 
complicated organic or bioorganic reactions catalyzed by thiazole-derived 







Scheme 1.2 The first isolation of a free N,S-heterocyclic carbene 
 
1.1.5 Development of Metal-NSHC Chemistry 
In the past decades, numerous applications of N,S-heterocyclic carbenes in 
organocatalysis have been explored,41-44 whereas metal based 
N,S-heterocyclcic carbene complexes and their catalytic properties are less 
developed. Early work on metal-NSHC chemistry was carried out by 
Lappert’s group and Stone’s group.14,45-46 Lappert et al. reported the 
Rh(I)-NSHC complex in early 1974. In the same year, Stone et al. reported 
several cationic NSHC carbene complexes of Ir(III), Ni(II), Pd(II) and Pt(II). 
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Later on, they also reported Ir(I), Rh(I), Mn(I), Cr(0) and Fe(0)-NSHC 
complexes. These complexes were characterized by NMR or IR spectra but 
without crystallographic evidence. No further progress was reported in 
metal-NSHC chemistry for one decade after the work of Lappert and Stone. 
Cr(0)-NSHC complex was reported by Raubenheimer’s group in 1985,36 
followed by the first crystallographically determined neutral Au(I)-NSHC 
complex in 1990 by the same group.37 The study was then extended to Cu(I), 
iron(II), molybdenum(0) and tungsten(0) during the period of 1995 to 
2004.38,39,47-49  
Calò and co-workers reported the structure and catalytic properties of 
Pd(II)-NSHC complexes in 2000.50 They found that these complexes are 
active toward arylation of butyl acrylates, Suzuki coupling, arylation of 
β-substituted acrylates and so on.51-55 Although their activities in most cases 
are not superior to the well-developed palladium N,N-heterocyclic carbenes, it 
is still impressive to see that these Pd-NSHC complexes were unique catalysts 
for carbonylation of aryl halides. 
Recently, Hahn and Huynh et al. reported the Rh(I)/Ir(I)-NSHC complexes 
with coordinated allyl substituent on the nitrogen atom.56-57 Grubbs et al. 
reported that Ru(II)-NSHC complexes could be applied in olefin metathesis.28 
Despite their less steric protection on the sulfur atom, these Ru(II)-NSHC 
complexes are competent catalysts for olefin metathesis reactions. They are 
unexpectedly robust and stable during the catalytic process. 
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Our group has developed a series of Ni(II)-, Pd(II)- and Pt(II)-NSHC 
complexes, and extended their catalytic studies to Mirozoki-Heck and 
Suzuki-Miyaura reactions.58-62 We also developed effective synthetic methods 
for novel Cu(I)-, Au(I/III)-NSHC complexes. These Cu(I)/Au(I/III)-NSHC 
complexes exhibited versatile coordination modes and reactivity.63-64 
The studies discussed above provide a useful entry for understanding 
metal-NSHC chemistry, and the results showing here pave the way to further 
explore their chemistry. 
 
1.2 Ru(II)-NHC Chemistry 
Recently reported Ru(II) complexes can be generally categorized into five 
groups according to their supporting ligand: carbonyl, tertiary phosphines, 
cyclopentadienyl, arene/dienes and carbenes. These ligands have proven to 
serve effectively as the activating factors such as generation of coordinatively 
unsaturated species by the liberation of ligands or stabilization of reactive 
intermediates. Recent studies reminded that the carbene ligands are especially 
specific for types of organic reactions. Continuous interest in this area is to 
explore new Ru(II)-NHC catalysts beyond metathesis to match a wide range 
of substrates and consequently for industry processes. 
1.2.1 General Synthetic Methods for Ru(II)-NHC Complexes 
Many strategies have been employed to prepare metal-NHC complexes, 
depending on the metal of interest. NHCs can be introduced as imidazolium 
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salts, as free carbenes or via transmetalation routes. Typical methods for 
Ru(II)-NHC complexes are given below. 
1.2.1.1 Lappert Method 
The Lappert method referred to the insertion of a metal into the C=C bond of 
bis(imidazolidin-2-ylidene)-based electron-rich olefins.65 For example, 
treatment of bis-imidazolin-2-ylidene and [RuCl2(p-cymene)]2 in boiling 
toluene for 4 h afforded the expected carbene-ruthenium-(p-cymene) complex 
as shown in Scheme 1.3.66 However, this method has its own limitation as this 
equilibrium is not accessible for all cases, viz. the dissociation of 
tetraaminoethylenes is not always applicable. This is reminiscent of the early 
work of Wanzlick et al. who proposed equilibrium between free 
imidazolin-2-ylidene carbene and its dimer (tetraminoethylenes).67 (Scheme 
1.4) Wanzlick equilibrium was questioned for quite a long time though it was 
later proved to be correct by Böhm, Herrmann, Hahn and etc.68-72 Thus, the 
Lappert method is not suitable for cases where the tetraaminoethylenes are not 
dissociated. In addition, the reaction condition is generally harsh with high 





Scheme 1.3 Lappert method for Ru(II)-NHC complex 
 
 
Scheme 1.4 Wanzlick equilibrium 
 
1.2.1.2 Proton Abstraction 
The most common synthetic method is direct complexation of divalent 
carbene. Preparation of a free carbene is through deprotonation of 
imidazolium salts at the C2-position under basic conditions. This method has 
been widely carried out for the synthesis of Ru(II)-NHC complexes. For 
example, Herrmann-Grubbs NHC-ruthenium complexes were readily accessed 
in toluene or tetrahydrofuran at room temperature, leading in high yield of 
products with imidazol-2-ylidene ligands.73 (Scheme 1.5) This is the method 
of choice for Ru(II) complexes with stable NHC carbenes. If the free NHCs 
are easy to dimerize at room temperature, the reaction should be handled with 















R = Ph; R' = tBu
R = Cy; R' = Cy  
Scheme 1.5 Proton abstraction method for Ru(II)-NHC complexes 
 
1.2.1.3 Transmetalation from Silver 
Ag(I)-NHC complexes can be used as good carbene transfer agents developed 
by Lin.74 It provides an alternative procedure to form new metal carbene 
complexes, avoiding the use of high temperature or strong base. This method 
was extended to ruthenium-NHC complexes very smoothly. Peris et al. 
reported a series of “Ru(p-cymene)” N-heterocyclic carbene complexes by 
silver transmetalation method in 2008.75 (Scheme 1.5) However, the key 















X X = CH3, Ph  
Scheme 1.5 Silver transmetalation method for Ru(II)-NHC complexes 
 
1.2.1.4 In situ Generation 
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Louie and co-workers reported in 2004 that the CO2 adducts of 
1,3-dimesitylimidazol-2-ylidene (IMes) and 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (IPr) were labile 
zwitterionic compounds that readily exchanged their carboxylate group in 
solution.76 These observation prompted Delaude’s group to investigate the 
reactivity of imidazolium-2-carboxylates with ruthenium-arene complexes. 
Several Ru-NHC complexes were isolated by this method shown in Scheme 
1.6.77 This method was also employed to synthesize second generation 
ruthenium metathesis catalysts.78 
 
 
Scheme 1.6 In situ generation method for Ru(II)-complexes 
 
In addition, a strong or weak base (such as KH, KOBut or NEt3, NaOAc) 
can be used to deprotonate an imidazolium salt in situ. This method is very 
facile in the preparation of Ru(II)-NHC complexes. Several new Ru-p-cymene 
complexes with chelating bis-N-heterocyclic-carbene ligands were reported in 





Scheme 1.7 In situ generation method for Ru(II)-complexes 
 
1.2.1.5 Oxidative Addition 
Abnormally bound Ru(II)-NHC complexes have been synthesized by 
oxidative addition. As shown in Scheme 1.8, Roper type complex 
Ru(CO)2(PPh3)3 reacted with phosphine-tethered imidazolium salt to give 




Scheme 1.8 Oxidative method for Ru(II)-NHC complexes 
 
1.2.1.6 Template Synthesis 
Template synthesis of metal-carbene complexes may be dated back to 1925. 
This method was unintentionally applied by Tschugajeff and 
Skanawy-Grigorjewa.81 The general idea of this method is the addition of HX 
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to coordinated functional isocyanides which contain both the isocyanide group 
and the nucleophile in the same molecule. Metal heterocyclic carbene 
complexes are accessed through an intra-molecular 1,2-addition across the 
C≡N triple bond. Some interesting modifications of this reaction have been 
reported recently by Hahn’s group.82-83 This study has been successfully 























Scheme 1.9 Template synthesis of Ru(II)-NHC complex 
 
1.2.1.7 Thermal Elimination of H-X from Carbene Precursors 
Waymouth, Hedrick and co-workers recently reported the base-free synthesis 
of a new set of air-stable NHC adducts that use a pentafluorophenyl 
substituent as a protecting group. These adducts are formed by the 
condensation of the diamines and pentafluorobenzaldehyde and were shown to 
decompose to the corresponding carbenes by mild heating.84 This method was 
further explored to access ruthenium-NHC complexes in 2007 by Grubbs et al. 




Scheme 1.10 Thermal Elimination method for Ru(II)-NHC complex 
 
1.2.2 Classes of Ru(II)-NHC Complexes 
As increasing efforts being put on Ru(II)-NHC chemistry, a series of structural 
motifs for Ru(II)-NHC complexes are emerging. Each motif contains, in 
addition to functional carbene ligands, a variety of ancillary ligands or 
non-innocent ligands. By adjusting these mixed ligands, the electronic and 
steric performance of ruthenium-NHC complexes could be fine tuned which in 
turn affect their catalytic properties. These Ru-NHC complexes can be roughly 
divided into the following two classes: ruthenium mono-NHC and bis-NHC 
complexes. Mono-NHC complexes can be further categorized into several 
sub-classes according to their ancillary ligands. 
1.2.2.1 Ruthenium Mono-NHC Complexes 
A wide range of ruthenium mono-NHC complexes have been reported. One of 
the most notable examples is the second generation Gurubbs catalysts 1.2 and 
1.3 reported in 1999 by Nolan and Grubbs.21,26 They serve the same purpose in 
organic synthesis as the first generation catalyst, but with higher activities. The 
framework of these catalysts contains one carbene ligand and one 
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mono-phosphine ligand in trans position. These complexes with mixed 




Surprisingly, ruthenium complexes with mixed N-heterocyclic carbene and 
diphosphine ligands are generally rare in reported references.86-88 Diphosphine 
ligands were introduced to ruthenium NHC complexes by Whittlesey and 
Williams to stabilize the ruthenium center (examples 1.4-1.7). Complex 1.4 
was active towards the Knoevenagel reaction. The activation of C-H/F bonds 
were examined for complexes 1.5-1.7. These complexes share a common 































Ru-NHC hydride complexes have proven catalytically active. Emerging 
examples include complexes 1.8-1.11 which can catalyze hydrogenation and 
isomerization reaction of alkenes.89-92 They were easily prepared by 
substitution of one phosphine ligand with NHCs from bis-phosphine 
precursors. Another interesting example is complex 1.12 consisting of 
tetrakiscarbene ligands. Complex 1.12 reacted with molecular oxygen to give 






Another catalytically active type is Ru-NHC arene complexes.75,94-97 These 
type of complexes are easily prepared from commercially available ruthenium 
dimer [RuCl2(p-cymene)]2 with carbene ligands. For example, complexes 
1.14-1.16 have been applied to radical and metathesis reaction. They are 
believed to have potential as precursors to new ruthenium NHC arene 















1.15: R = aryl, alkyl










1.16: R = alkyl  
 
As recycling becoming more and more important in modern chemistry, 
immobilization of well-defined Ru-NHC homogeneous catalysts timely 
emerged.98 As the NHCs strongly bound to metal center, they may function as 
supporting ligands. The ruthenium complexes may further immobilized in a 
variety of polymers and silica. For example, Blechert and co-workers reported 
Ru-NHC complex 1.17 supported by poly(styrene)-based Merrifield resin.99 
This catalyst could survive a series of organic reactions and be easily 
recovered by simple filtration. Recently, Shi et al. reported the synthesis of 
anchored catalyst 1.18 through one of the NHC arms by SBS-15.100 It was 





















Due to the ease of introduction of functional donor groups (O, S and N) to 
NHC ligands or activation of C-H bond on the nitrogen arms, ruthenium 
mono-NHC complexes are found with not only simple monodentate 
coordination mode but also chelating even tridentate mode. Recent examples 
of chelating coordinated carbenes include complexes 1.19 and 1.20. Complex 
1.19 was synthesized by silver transmetalation method.101 The chelating mode 
is supported by pyridine group. Complex 1.20 represents the chelating carbene 
ligand facilitated by C-H bond activation. It is one of the isomers of isolated 
products.102 The other isomers with phosphine in a cis-position or carbonyl 
and phosphine in trans-position were also isolated. This study contributed to 
the understanding of the different activities between six- and five-membered 
ring carbene complexes. Hahn et al. reported water and air stable complex 












1.2.2.2 Ruthenium bis-NHC Complexes 
The chelating or triscoordinated mode could be formed in ruthenium bis-NHC 
complexes based on the functionalities linked to carbene ligands. The 
bis-NHC ligands for ruthenium complexes are generally presented with linker 
between two carbene skeletons as shown in Scheme 1.11. Two carbene ligands 
joined together without linker also exists as an exceptional example.104 For 
example, complexes 1.22 and 1.23 were reported by Crabtree and Peris in 
2008. In complex 1.22, the carbene ligand adopted chelating mode while it is 








Two carbene skeletons in chelated Ru-NHC complexes were observed in 
trans- or cis- orientation depending on the space of linkers. As shown below, 
complexes 1.24–1.26 were prepared by the free carbene route.79,104-105 Two 
carbene skeletons are in trans position in complex 1.24 and 1.25 while cis 




The carbene 2,6-pyridyl-bisimidazole-2-ylidene is among the most known 
pincer ligand for Ru-bis-NHC complexes. Several ruthenium complexes 
1.27-1.33 were synthesized of which complexes 1.27 and 1.28 are efficient 
catalysts towards transfer hydrogenation reactions.106-109 This may be ascribed 
to the strong affinity of pincer ligand to metal center. Complex 1.29 was not 
active to the same catalytic reaction as a result of blocked coordination sites 
and lack of labile bond for the metal center. However, this complex showed 
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the longest luminescent lifetime among the known ruthenium pyridyl 
complexes. Complex 1.30 exhibited activities towards ring-opening metathesis 
polymerization of cyclic alkenes and ring-closing metathesis of diethyl 
2,2-diallyl-malonate. Nevertheless, its activity was a bit lower compared with 







































Ruthenium-NHC-aqua complexes were also observed by using this 
bis-carbene ligand. Complex 1.31 and 1.32 were emerging as two isomers 
with different trans ligands to pincer carbene carbon. Theses aqua complexes 
1.31–1.33 could experience a proton-coupled oxidation. Thus, they were 
applied in epoxidation catalytic reaction of cis-β-methyl-styrene. The results 
showed that the use of complex 1.31 and 1.32 preferred generation of 
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R = nBu R = nBu R = nBu
1.31 1.32 1.33  
 
1.2.3 Catalytic Study of Ru(II)-NHC Complexes 
As a consequence of the difficulties in correlating the catalysts-substrates 
relationship, the development of efficient ruthenium catalysts is rather slow. 
Indeed, until the 1980s the reported useful catalytic properties of ruthenium 
catalysts were limited to a few reactions which included oxidations with RuO4, 
hydrogenation reaction and transfer hydrogenations. As the coordination 
chemistry of ruthenium complexes progressed, specific characters of 
ruthenium have been made clear. Therefore, a large number of novel, useful 
reactions have begun to be developed using catalytic amounts of ruthenium 
complexes. A notable example is Grubbs catalyst based on Ru-NHC 
complexes for olefin metathesis reaction. The Royal Swedish Academy of 
Sciences decided to award the Nobel Prize in chemistry for 2005 to Yves 
Chauvin, Robert H. Grubbs and Richard Schrock “for the development of the 
metathesis method in organic synthesis”. Triggered by this, Ru-NHC 
chemistry which combines high reactivity with good tolerance to a wide range 
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of functional groups has seen explosive growth in organic synthesis. Some of 
their recent applications beyond metathesis in catalysis are illustrated below. 
1.2.3.1 Transfer Hydrogenation 
Transfer hydrogenation is an attractive alternative to common catalytic 
hydrogenation where the high pressure hydrogen gas is used. Compared with 
the previous methods, transfer hydrogenation provides a more safe and simple 
operation and low costs with catalytic amounts of Ru-NHC complexes.110-111 
















Scheme 1.12 Transfer hydrogenation reaction 
 
An array of new RuCl2(NHC)(p-cymene) monodentate complexes 1.34a-e 
has been applied for reduction of ketones to corresponding alcohols by 
Çetinkaya’s group. (Scheme 1.12) They reported that introduction of 
electron-withdrawing substituents (F, Cl, Br) in the meta position of the aryl 





1.34a: R = C2H5OC2H4, R' = C2H4C6H5
1.34b: R = CH2C6H2(CH3)3, R' = C2H4C6H5
1.34c: R = CH2C6H2(CH3)3, R' = CH2C12H9
1.34d: R = C2H5OC2H4, R' = CH2C12H9






























Several ruthenium complexes (1.19, 1.27–1.28, 1.35–1.36) based on 
bidentate as well as tridendate carbene ligands have also been applied to this 
catalytic reaction.106-107,112-113 Complex 1.19 with bidentate carbene ligand is 
efficient in reduction of alkyl or aryl ketones to alcohols. However, its scope is 
limited to 4-methoxyacetophenone and 2,4,6-trimethylacetophenone due to the 
electronic and steric effects of the substituents on the ketones. While the 
pincer carbene ligands are introduced, the catalytic activities are further 
improved. An outstanding example is complex 1.27 which can catalyze the 
reaction in air. Complex 1.28, sharing the same carbene ligand with complex 
1.27, displays lower turnover numbers, however, the reaction is carried out at 
lower temperatures. Complex 1.35 is a pincer carbene based cationic dimer. It 
is also employed for the hydrogenation of cyclohexanone, acetophenone or 
benzophenone with iPrOH in the presence of KOtBu or KOH. To avoid the use 
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of base, complex 1.36 was rationally designed. Its application in transfer 
hydrogenation can be carried out at optimized temperature of 50 °C with 2 
mol% catalysts loading. The above data reminded that bidentate or tridentate 
carbene complexes are generally more active than monodentate carbene 
complexes. However, the catalytic activities of these Ru-NHC catalysts are not 
as good as the well-defined non-Ru-NHC catalysts such as Noyori catalysts. 
The current Ru-NHC system needs to be further modified. 
1.2.3.2 Hydrosilylation of Alkynes 
The hydrosilylation of alkynes normally generates three regioisomers: α, β(E), 
and β(Z) isomers. (Scheme 1.13) In particular, the choice of transition metal 
significantly influences the outcome of the reaction. Rhodium catalysts have 
been employed for the selective generation of both E- and Z-vinylsilanes. The 
Z-isomer can be  generated from iridium and ruthenium catalysts. However, 
hydrosilylation of alkenes/alkynes by Ru-NHC complexes is generally absent 









Complexes 1.2–1.3 and 1.37–1.38 were introduced to examine their 
activities in transfer hydrosilylation. In the reaction between phenylacetylene 
and triethylsilane at 65 °C, catalysts 1.2 and 1.3 showed moderate yields while 
significant amounts of tail-to-tail phenylacetylene dimer were also 
generated.114 Later on, Dalko, Cossy and co-workers examined the reaction 
between butyn-3-ol derivatives and triethylsilane by using complexes 1.37 and 
1.38 as catalysts.115 Both of them gave moderate yields with low 
regioselectivities. The mechanism of Ru-NHCs catalyzed hydrosilylation is 
the subject of the Harrod-Chalk’ and Markó’ groups.116-117 Future work will 
focus on exploring more active catalysts and illuminating the catalytic 
mechanisms.  
1.2.3.3 Isomerization 
The hydrogenation and metathesis of alkenes catalyzed by ruthenium 
complexes are often accompanied by double bond migration and cis-trans 
isomerization. An interesting example is isomerization of 1-octene to 2-octene 
at higher temperatures (80-120 °C) by complex 1.39.118 The obtained yield is 
around 90%. Due to the similar catalytic behavior of 1.39 and 
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RuHCl(CO)(PCy3)2, Mol and Dinger proposed that the real catalyst was 
ruthenium hydride complex in situ generated from 1.39.118 However, while the 
nitrogen arms of carbene ligand shifted to isopropyl group, catalyst 1.11 
exhibited moderate yield of 67% isomerization product with cis/trans 33:67.119 
In addition, isomerization is usually accompanied by hydrogenation product 
when terminal olefins are used and their relations were discussed by Fogg and 









The isomerization of ally alcohol/ether is another interesting paradigm. 
(Scheme 1.14) For example, Ru-NHC complexes 1.40 and 1.41 were 
examined in the isomerization of (Z)-but-2-ene-1,4-diol. The (E)- 
but-2-ene-1,4-diol isomer was collected in 70% yield at room temperature for 
15 min.120 Promisingly, use of complex 1.42 lead to 95% yield under the same 
condition. When the substrate changed to prop-2-en-1-ol, and the reaction 
carried out in dichloromethane using complex 1.2 as catalyst, the metathesis 
product but-2-ene-1,4-diol along with isomerization product propionaldehyde 
was observed.121 Both the yields of diol and aldehyde products were increased 
by changing the catalyst to substrate ratio from 1:100 to 1:10. In addition, the 
isomerization pathway was prohibited by changing to oxygen donor solvent. 
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To scope the reaction of catalyst 1.2, O- and N-allyl substrates were employed. 
They generally afforded enol ether in high yield around 90% but enamine in 
21%.122 Recent examples catalyzed by complex 1.2 involved the formation 
apirocyclic diene-2-azetidinone.123 In this reaction, isomerization reaction took 
place first, followed by RCM. Lately, sulfonate-functionalized NHC-based 
ruthenium complexes 1.43 were tested for isomerization of allylic alcohols to 
acetones in water. Catalyst 1.43 has proven to be very effective. More 
prominently, this catalyst could be recycled and did not lose activities after 
several cycles.124 Although olefin isomerization is usually considered as side 
reaction in olefin metathesis, it may also be an independent reaction if proper 
condition is given. Sometimes effective combination of metathesis 
(ring-closing/opening metathesis or cross-metathesis) and isomeriztion may 









Catalytic activity of ruthenium complexes for the cyclopropanation of olefins 
with diazoacetate was first described in 1980 by Huber and Noels.125 At that 
time, the efficiency of ruthenium catalyst Ru2(OAc)4Cl was lower than 
palladium, rhodium and copper catalysts. (Scheme 1.15) Subsequent studies 
were focused on designing new ruthenium complexes bearing diverse ligands, 





















Complex 1.44 was shown to have good activity for the cyclopropanation as 
well as good selectivity for cis/trans (18:82) isomers.127 A comparison of the 
data revealed that the EDA is a particularly effective substrate. With the use of 
N2Ph or N2SiMe3 as substrates, both the reactivity and selectivity were 
decreased. Delaude’s group reported the same reaction catalyzed by a broad 
array of Ru-NHC complexes 1.14.77 These ruthenium complexes are generated 
in situ by treatment of imidazolium salts with [RuCl2(p-cymene)]2 in the 
presence of strong base potassium tert-butoxide or sodium hydride. The 
cyclopropanation of the styrene double bond proceeded in high yield (80-85%) 







1.2.3.5 Alkyne C-C Coupling 
The transition metal mediated dimerization of terminal alkynes is of interest as 
it can produce a number of organic enyne and oligoacetylene products which 
are useful for organic polymers and natural product synthesis. Herrmann and 
Baratta have stated that dimerization of alkynes gave corresponding enynes by 
Ru-NHC catalysts 1.45.128 Catalysts 1.45 presented as one of the most active 
catalysts for alkyne dimerization even today. The selectivity of products I-III 
is dependent on the R group of alkynes. (Scheme 1.17) More specifically, the 
reaction preferred to form I by using Ph group; however, III was prior to 
generate while R = SiMe3. Recently, Peris et al. reported ruthenium based 
abnormal carbenes 1.46-1.48 as catalysts for this type of reaction.75 Their 
yields are satisfactory with more than 80%, but the selectivity is much poorer 














R = Ph, p-Tol, SiMe3 I II III  









1.45a: R = Cy







1.46a: R = CH3














1.2.3.6 Arylation of Arene C-H Bond  
Additions of aromatic C-H bond to arenes results in the formation of aryl-aryl 
bonds. This type of reaction was first disclosed by Catellani and Chiusoli in 
1985.129 However, Ru-NHC complexes applied in this reaction only began in 
2008 by Dixneuf et al..130 The catalysts were generated in situ as shown in 
Scheme 1.18. The arylation products were obtained in 58-89% yields. These 
catalysts could tolerate differenct arene bromide substrates with good yields. 
Their mechanism was evaluated by DFT calculations. Özdemir et al. extended 
this study by isolating the pre-catalysts 1.49 before catalytic reactions.131 The 
reaction performed well in NMP with Cs2CO3 or KOBut as base at 120 °C. 
Under this reaction condition, a wide range of aryl halides bearing 
electron-donating or electron-withdrawing groups can react with 
2-phenylpyridine, affording the arylated products in excellent yields. 
Subsequently, Dixneuf et al. reported the ruthenium dicarbene complexes 1.50 
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and 1.24 for this type of reaction.132 The reaction was carried out under the 
similar condition to give the di-ortho-arylated products as major products 






























R = CH2OMe, R' = Mes
R,R' = CH2OMe




1.3 Objective of the Project 
In view of the progress summarized above, it is convincing that both the 
synthesis and catalytic studies of Ru(II)-NSHC chemistry are less explored. 
The time is right to explore their chemistry and expand their catalytic 
properties beyond the established ones. Additionally, NSHC complexes of the 
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inexpensive metal Ni(II) will be explored for the first time and are elucidated 
in the last chapter. 
The specific aims are to: 
1) synthesize new Ru(II) and Ni(II) complexes from various N,S-heterocyclic 
carbene precursors and determine their structures. 
2) correlate the ligand-structure and structure-property relationships through 
ligand modification. 
3) expand the catalytic reactions to Ullmann coupling, transfer hydrogenation 
and hydrosilylation. 
4) study reactivities of Ru(II)-NSHC complexes with acid (maleic acid) or 
base (free NNHC or NaOtBu). 
The incorporation of N,S-heterocyclic carbene ligands to Ru(II) and Ni(II) 
center should prompt some interesting structural features which may 
potentially intrigue in different types of catalytic reaction. Furthermore, 
because of the lack of parallel and comparative studies between NNHC and 
NSHC analogues, this work may contribute to a better understanding of 
N,S-heterocyclic carbene chemistry. 
Multidentate N,S-heterocyclic carbene ligands and carbenes with other 
heteroatoms (such as O and P) are beyond the scope of this study. The less 
sterically hindered N,S-heterocyclic carbene ligands may result in their 
instability during some catalytic processes, such a defect may be partly 
compensated by the introduction of multidentate N,S-heterocyclic carbene 
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ligands which may worth further endeavor. This work only demonstrated 
limited uses of NSHC complexes in catalysis and further research is invited to 
explore the wide scope of their applications in catalysis and beyond. 
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Chapter 2 Ruthenium(II) N,S-Heterocyclic Carbene 
Complexes and Transfer Hydrogenation of Ketones  
 
2.1 Introduction 
Ruthenium(II) complexes especially Ru(II)-NHC complexes have gained 
intense attention in recent years as powerful and efficient catalysts in an array 
of organic transformations.124,133-139 One of the well celebrated examples is the 
N,S-heterocyclic carbene-based ruthenium complexes 
RuCl2(3-R-DMeTh)(=CH-o-iPrO–Ph) (DMeTh = 
4,5-dimethylthiazol-2-ylidene; R = phenyl, 2-methylphenyl, 
2,4,6-trimethylphenyl, 2,6-diethylphenyl, 2,6-diisopropylphenyl) and 
RuCl2(3-R-DMeTh)(=CH-Ph)(PCy3) (R = 2,4,6-trimethylphenyl, 
2,6-diethylphenyl) developed by Grubbs et al.28 These catalysts displayed 
improved catalytic activity, functional group tolerance and thermal stability 
compared to its first-generation counterpart. In addition, different from the 
majority of other N-heterocyclic carbene (NHC) ligands, the NSHC ligand on 
these Ru(II) complexes have only one exocyclic substitutent. The aryl 
substituent tends to protect the vacant site of the metal. This is in contrast with 
their asymmetric NNHC counterparts which bear two exocyclic (typically aryl 
with alkyl) substituents.140-142 Despite the lower steric protection in a 
single-substituent ligand, these Ru(II) catalysts are unexpectedly robust, and 
matching their NHC counterparts in terms of stability and activity towards 
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metathesis.143-147 Encouraged by these, and as part of our study towards metal 
NSHC complexes,58-64 we will discuss a new series of Ru-NSHC complexes in 
this chapter, which are different from Grubbs’ complexes in carrying the 
benzothiazol-2-ylidene carbene.  
We will also report their catalytic activites towards transfer hydrogenation, 
which has been applied to ketones in the preparation of alcohols under mild 
conditions.27,111,148-153 Such method obviates the use of high hydrogen pressure 
and hazardous reducing agents. Although Ru(II) NHC complexes are known 
to be transfer hydrogenation active,97,106-107,112-113,154-156 the activities of their 
NSHC counterparts are insofar unknown. Thus, it is important to explore these 
NSHC counterparts which may make up for the lack of parallel and 
comparative studies between NNHC and NXHC analogues. 
 
2.2 Results and Discussion 
2.2.1 Synthesis of Benzothiazolium Salts 
Benzothiazolium bromide/iodide salts [(C6H4)SCHNR]X (R and X = Bz and 
Br (L1); Pri and I (L2); Bui and I (L3)) with different nitrogen substituents 
could be obtained as off-white or light yellow powder in good yields (>90%) 
by treatment of the freshly distilled benzothiazole and appropriate alkyl halide 
at r.t. (L1) or 80 °C (L2–L3) using a solvent-free method (Scheme 2.1).58 
Their 1H NMR spectra invariably show downfield resonances for the SCHN 
protons in the range of 11.38–12.25 ppm. Molecular ions [L–X]+ (L = L1–L3, 
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X = Br/I) were observed in the ESI-Mass spectra at 178.0 (L2) and 192.1(L3) 




Scheme 2.1. Synthesis of benzothiazolium salts L1–L3 
 
2.2.2 Synthesis and Characterization of Complexes 2.1–2.6 
The benzothiazolium salts L1, L2 and L3 ([(C6H4)SCHNR]X (R and X = 
Bz and Br (L1); Pri and I (L2); Bui and I (L3)) undergo a one-pot 
condensation reaction with Ru(RCOO)2(PPh3)2 (R = Me, Et)157 in the 
presence of NaOOCR (R = Me, Et) to give the corresponding mixed 
phosphine-carbene complexes RuIIX(RCOO)(PPh3)2(3-R’BzTh) (BzTh = 
benzothiazol-2-ylidene; R = Me, R’/X = Bz/Br (2.1), Pri/I (2.3), Bui/I (2.5); 
R = Et, R’/X = Bz/Br (2.2), Pri/I (2.4), Bui/I (2.6)) in moderate yields 
(40–61%) (Scheme 2.2). It should be noted that although the preparation of 
the ruthenium starting materials Ru(PPh3)2(RCOO)2 (R = Me, Et) is facile 
and has been established four decades ago, their latent applications in 
Ru-carbene chemistry have not been scrutinized. We reasoned that 
Ru(PPh3)2(RCOO)2 (R = Me, Et) will be promising starting materials as the 
acetate may function as proton scavenger (i.e. base) and simultaneously 
serve as leaving group in the reaction system, thus leaving the empty 
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coordination sites for the in situ generated free N,S-heterocyclic carbenes, 
and therefore facilitate the formation of desired Ru-carbene complexes. In 
addition, there is no evidence of phosphine replacement by carbene. Instead, 
entry of the latter, and chloride, is facilitated by the carboxylate departure 
in form of carboxylic acid. Similar reaction of RuCl2(PPh3)3 with L1 and 
NaOAc in THF, which is a method adopted in the preparation of Ru(II) 
NNHC complexes,158-160 only gave [1,3]-benzyl migration product, but not 
the desired complex.161 Preparations without addition of NaOAc also lead 
to incomplete reactions and other side products. The products prepared are 
probably the most stable complexes in this series because use of 2-3 fold 
excess of L1, L2 and L3 with Ru(RCOO)2(PPh3)2 did not yield any 
di-carbene or phosphine displacement products.  
These complexes are more stable in solid state than in their solution state. 
They are readily soluble in CH2Cl2, THF and toluene whereas slightly 
soluble in diethyl ether. Their elemental analyses data are consistent with 
their chemical formulae. The formation of Ru-carbene complexes were 
further evidenced by the disappearance of the NCHS protons in 2.1–2.6 
compared with their respective benzothiazol-2-ylidene salts L1–L3 in 1H 
NMR spectra, as well as the appearance of the diagnostic carbenoid carbon 
signal in the 226.0–230.1 ppm region in their 13C NMR spectra. The 





Scheme 2.2. Synthetic route of Ru(II)-(benzothiazol-2-ylidene) complexes 2.1–2.6 
 
2.2.3 Molecular Structures of Complexes 2.1–2.6 
The structures of 2.1–2.6 were unequivocally elucidated by single-crystal 
X-ray diffraction studies. They are invariably mononuclear with 
trans-phosphine, as well as NSHC and halide trans to chelating carboxylate in 
a distorted octahedral Ru(II) sphere (Figure 2.1 and Table 2.1). The 
phosphines in Ru(RCOO)2(PPh3)2 (R = Me, Et) are also trans oriented. The 
P-Ru-P alignments are heavily distorted from linearity [P-Ru-P: 173.63(6)° 
(2.1); 169.03(3)° (2.2); 164.55(2)° (2.3); 171.09(2)° (2.4); 164.55(2)° (2.5); 
170.08 (2)° (2.6)] which could reflect the non-bonding contacts between the 
NSHC substituent with the phenyls in PPh3. For example, in 2.3, there are 
short H…H contacts between the carbene N-substituent and phosphine 
phenyls, such as  the methyl H9A and phenyl H6A (2.26 Å) as well as the 
methine H8 and phenyl H2E (1.98 Å) (Figure 2.1). These complexes are static 
in solution, each showing only a single δP resonance suggesting phosphine 
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equivalence. The Ru-C bonds (1.966(2)–2.003(2) Å) are within the range 
between those reported Ru-NSHC complexes such as 
RuCl2(3-R-DMeTh)(=CH-o-iPrO–Ph) (DMeTh = 
4,5-dimethylthiazol-2-ylidene; R = phenyl) (1.944(1) Å) and 
RuCl2(3-R-DMeTh)(=CH-o-iPrO–Ph) (R = 2,4,6-trimethylphenyl) (1.953(1) 
Å)28 and Ru-NNHC complexes such as [RuCl3(NO)(NHC)] (NHC = 
3-tert-butyl-1-(2-pyridyl)imidazol-2-ylidene) (2.049(5) Å)113, 
[RuF(H)(PPh3)2(CO)(NHC)] (NHC = 1,3,4,5-tetramethylimidazol-2-ylidene) 
(2.170(2) Å)162 and mer, cis-[RuCl2(CO)(NHC)] (NHC = 
1,3-bis(2-diphenylphosphanylethyl)-3H-imidazol-2-ylidene) (2.038(3) Å)112. 
There is no crystallographic report in the literature on phosphine containing 
Ru(II)-NSHC complexes. The slightly shorter Ru-C in NSHC compared to 
NNHC complexes could be attributed to a lower steric demand of the former 
and its more electron rich and nucleophilic carbenic carbon resulting from its 
diminished pπ-pπ interactions with the neighboring heteroatoms. The Ru-C 
bond lengths of the isopropyl analogues (2.3 (1.981(3) Å) and 2.4 (2.003(2) Å)) 
are longest in this series, perhaps reflecting higher inter-ligand repulsions. The 
Ru-P lengths (2.374(2) Å to 2.411(5) Å) lie within the expected range of 
2.40±0.05 Å in trans-RuII(PPh3)2 species.162-165 The chelating carboxylate 
oxygen, carbenic carbon and halide ligands constitute a nearly perfect 
equatorial plane (mean deviation, 0.0217 Å (2.1); 0.0127 Å (2.2); 0.0209 Å 
(2.3); 0.0058 Å (2.4); 0.0095 Å (2.5); 0.0251 Å (2.6)). Stronger 
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trans-influence of carbene compared to halide imparts a significant disparity 
between the two Ru-O lengths (Ru1-O1 (2.128(2) to 2.163(2) Å) being 
significantly stronger than Ru1-O2 (2.241(2) to 2.283(2) Å)).166-170 The 
carboxylate ligands thus adopt more an asymmetric η2-chelating mode. The 
heterocyclic planes in 2.1, 2.2, and 2.4 are nearly co-planar with the equatorial 
coordination planes defined by O1O2XC1 (X = Br, I) whereas in 2.3, 2.5 and 
2.6, they are twisted to give unequivocally dihedral angles of 27.3° (2.3), 
24.8° (2.5) and 26.6° (2.6). The latter rotations help to relieve the short 
repulsive H…H contacts between methyl (2.3 and 2.6) or methine group (2.5) 
with the phenyl ring, i.e., H9A and H6A (2.26 Å (2.3)), H9 and H2D (2.06 Å 
(2.5)) and H10C and H2B (1.86 Å (2.6)) (Figure 2.1). The hydrogen atoms 
from benzyl ring in complexes 2.1 and 2.2 project to the center of phenyl ring 
and are therefore shielded. Accordingly, the H10 and H14 of benzyl ring in 2.1 
are upfield shifted to 5.58 ppm. This shielding effect was confirmed by 1H 
NMR and 2D 1H-1H correlation spectra. 
 
 




2.3                                 2.4 
 
 
2.5                               2.6 
 
Figure 2.1. Ortep diagrams of the structures of 2.1–2.6 with 50% probability ellipsoids 
and labelling scheme, and Ortep diagrams of 2.3, 2.5 and 2.6 showing short H···H 
contacts 
 
Table 2.1. Selected bond lengths (Å) and angles (°) for 2.1–2.6 
 2.1 2.2 2.3 
Ru(1)-C(1) 1.970(6) 1.970(3) 1.981(3) 
Ru(1)-O(1) 2.130(4) 2.163(2) 2.283(2) 
Ru(1)-O(2) 2.241(4) 2.251(2) 2.128(2) 
Ru(1)-P(1) 2.393(2) 2.3820(9) 2.3741(7) 
Ru(1)-P(2) 2.374(2) 2.3825(9) 2.3898(7) 
Ru(1)-X(1)a 2.543(1) 2.5553(4) 2.7221(3) 
P(1)-Ru(1)-P(2) 173.63(6) 169.03(3) 164.55(2) 
O(1)-Ru(1)-O(2) 60.2(2) 59.25(8) 59.12(7) 
S(1)-C(1)-N(1) 106.6(5) 106.5(2) 107.7(2) 
Dihedral angleb 3.9 9.7 27.3 
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 2.4 2.5 2.6 
Ru(1)-C(1) 2.003(2) 1.966(2) 1.976(2) 
Ru(1)-O(1) 2.149(2) 2.135(1) 2.134(1) 
Ru(1)-O(2) 2.242(2) 2.271(1) 2.241(2) 
Ru(1)-P(1) 2.3821(6) 2.3749(5) 2.3846(6) 
Ru(1)-P(2) 2.3949(6) 2.4112(5) 2.4031(6) 
Ru(1)-X(1)a 2.7356(3) 2.556(2) 2.7412(4) 
P(1)-Ru(1)-P(2) 171.09(2) 171.07(2) 170.09(2) 
O(1)-Ru(1)-O(2) 59.39(7) 59.29(5) 59.55(6) 
S(1)-C(1)-N(1) 106.8(2) 107.1(1) 106.6(2) 
Dihedral angleb 4.3 24.8 26.6 
    
a X = Br for 2.1 and 2.2 X = I for 2.3–2.6; b dihedral angle between the [O1O2XC1] and 
N,S-heterocyclic carbene planes 
 
A closer examination of the packing diagrams of the crystal structures 
revealed that each mononuclear complex is associated with its neighboring 
molecule(s) to form a two dimensional structure (2.1) or dimeric species 
(2.2–2.6) (Figure 2.2). In 2.1, one dimensional chain extending in the a 
direction is observed by alternant H-bonding between O2···H16C-C16 (2.667 
Å/144.80°) and S1···H6-C6 (2.883 Å/140°). Two dimensional network is 
formed by further hydrogen bonding among the chains in the b direction 
through Br1···H13-C13 H-bond (2.985 Å/129.23°). Nevertheless, in 2.2, only 
differing in its acetate group compared with complex 2.1, gives a dimer with 
its O2···H4F-C4F (2.630 Å/154.34 °) H-bonding interactions between two 
adjacent species. In addition, complexes 2.3-2.6 all form dimers with the 
effect of H-bond. The two ruthenium monomers in 2.3 are connected by the 
H-bonding between the oxygen (O2) and one of the methyl protons (2.601 
Å/159.07°) and two toluene molecules are attached to this dimer by 
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S1···H6S-C6S (2.902 Å/152.79 °) H-bonding which is observed in opposite in 
complex 2.4. The dimer in complex 2.4 is formed by S1···H5E-C5E (2.872 
Å/141.13°) H-bonding while toluene is attached interacted by 
O2··· H10S-C10S (2.639 Å/173.39 °) H-bonding. Although the dimer in 
complex 2.5 and 2.6 both results from the S···H bond, but hydrogen is from 





















Figure 2.2. Intermolecular hydrogen bonding of complexes 2.1–2.6 
 
2.2.4 Transfer Hydrogenation 
Complexes 2.1–2.6 have been screened on their activities towards transfer 
hydrogenation, using the reduction of p-methyl acetophenone to 
1-(4-methylphenyl)ethanol in the presence of 2-propanol as a model.(Table 2.2) 
All catalysts tested give satisfactory yields (77-91%) within 30 h at a catalyst 
load of 1 mol%. Complex 2.1, with benzyl substituent, is generally more 
active than the rest. It still returns with a yield of 80% even at a load down to 
0.5 mol%.(Table 2.2, Entry 5). Its effect on different alkyl and aryl ketones 
was hence further examined.(Table 2.3) It returns with excellent yields 
(90-96%) except towards benzophenone and 4-methoxyacetophenone (Entry 5 
and 6), which is probably attributed to the electronic and steric effects of the 
substituent on the ketones. 
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Table 2.2. Catalytic transfer hydrogenation of p-methyl acetophenone catalysed by 
complexes 2.1-2.6 
 
Entry Catalyst Time (h) Yield (%) 
1 2.1 6 49 
2 2.1 18 62 
3 2.1 26 84 
4 2.1 30 91 
5a 2.1 30 80 
6 2.2 30 80 
7 2.3 30 87 
8 2.4 30 77 
9 2.5 30 90 
10 2.6 30 84 
 
Experimental Conditions: ketone, 1 mmol; NaOBut, 0.1 mmol; Catalyst, 0.01 
mmol; 2-propanol, 15 mL; temp, 82°C. a catalyst loading 0.005 mmol 
 
Table 2.3. Catalytic transfer hydrogenation of ketones catalysed by complex 2.1 
Entry Substrate Product Yield (%) 
1 cyclopentanone cyclopentanol 96 
2 acetophenone 1-phenylethanol 90 
3 4-chloroacetophenone 1-(4-chlorophenyl)ethanol 94 
4 4-bromoacetophenone 1-(4-bromophenyl)ethanol 96 
5 4-methoxyacetophenone 1-(4-methoxyphenyl)ethanol 14 
6 benzophenone diphenylmethanol 3 
 
Experimental Conditions: ketone, 1 mmol; NaOBut, 0.1 mmol; Catalyst, 0.01 mmol; 
2-propanol, 15 mL; temp, 82°C; time, 30 h. 
 
The catalytic mechanism likely follows that established.111 Easy opening of 
the carboxylate chelate, especially through cleavage of the Ru-O bond trans to 
the carbene, would create room for entry of the ketone substrate. Exchange of 
halide (and carboxylate) with proton would lead to the active hydride species 
needed for hydrogenation transfer. These factors, coupled with the good 
49 
stability of these systems under redox conditions offer possible reasons for the 
satisfactory catalytic activities shown. These could be further improved by 
using polydentate carbene ligands which tend to lend higher stability to the 
catalysts. For example, similar reduction of acetophenone using catalytic 
[Ru(NO)(L)Cl3]113 (L = 3-tert-butyl-1-(2-pyridyl)imidazol-2-ylidene) can 
achieve a yield of 96% within a shorter period of 4 h. A small catalyst load of 
0.1 mol% fac-[Ru2(μ-Cl)3Cl2(PCNHCP)2]Cl (PCNHCP = 
1,3-bis(2-diphenylphosphanylethyl)-3H-imidazol-2-ylidene)112 can also 




Reported herein is a facile synthetic methodology that enables the 
introduction of a NSHC carbene ligand to the [RuII(PPh3)2] core. The 
presence of potentially labile and dissociable ligands on these cores, such 
as carboxylate and halide, make this catalytically viable and allows further 
ligand replacement to alter the electronic and steric traits of the complexes. 
The study here suggests that these complexes may be applied to area 
beyond metathesis.  
 
2.4 Experimental Section 
2.4.1 General Procedures and Materials 
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All manipulations were carried out under a nitrogen atmosphere using 
standard Schlenk techniques. Ligand N-benzylbenzothiazolium bromide (L1) 
was prepared according to the literature method.58 Ru(RCOO)2(PPh3)2 (R = 
Me, Et) were prepared according to the literature method.157 Other 
commercially available reagents were purchased from Sigma-Aldrich. All 
solvents were freshly distilled from standard drying agents. 1H (500.1 MHz), 
31P (202.4 MHz) and 13C(125.8 MHz) NMR spectra were recorded in ppm on 
a Bruker AMX 500 spectrometer. The chemical shifts (δ) are referenced to 
TMS for 1H and 13C{1H} and H3PO4(85%) for 31P{1H}. Elemental analyses 
were performed on a Perkin-Elmer PE 2400 elemental analyzer. The yields of 
hydrogenation products were determined by using Hewlett Packard Series 
6890 GC (Santa Clara, CA, USA) coupled to a Hewlett Packard 5973 MS 
detector. 
2.4.2 Preparation of Benzothiazolium Salts L2 and L3 
A mixture of benzothiazole (2.71 g, 20.0 mmol) and 2-iodo-propane (3.65 g, 
21.5 mmol) or 1-iodo-2-methyl-propane (3.72 g, 20.2 mmol) was stirred at 
80 °C overnight to yield a large amount of light yellow crude product, which 
was collected and washed with diethyl ether. The solid was then washed with 
dichloromethane to afford white solid, and dried in vacuum. 
N-isopropylbenzothiazolium iodide (L2) 
Yield: 5.74 g (18.8 mmol, 94%). 1H NMR (300.1 MHz, CDCl3): δ 11.38 (s, 
1H, NCH), 8.54 (d, 1H, 3JHH = 7.80 Hz, Ar–H), 8.28 (d, 1H, 3JHH = 8.70 
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Hz, Ar–H), 7.88 (t, 1H, Ar–H), 7.78 (t, 1H, Ar–H), 5.54 (m, 1H, CH), 1.91 
(d, 3H, CH3), 1.88 (d, 3H, CH3). 13C NMR (75.48 MHz, CDCl3): δ 161.6 
(NCS), 139.6, 130.9, 130.1, 128.9, 125.4, 117.3 (Ar–C), 57.0 (CH(CH3)2), 
22.2 (CH(CH3)2). MS (ESI, positive mode) m/z (%): 178.0 (100) [M – I]+. 
Anal. Calc for C10H12INS: C, 39.36; H, 3.96; N, 4.59. Found: C, 39.31; H, 
3.97; N, 4.52. 
N-isobutylbenzothiazolium iodide (L3) 
Yield: 6.02 g (18.8 mmol, 94%). 1H NMR (300.1 MHz, CDCl3): δ 11.56 (s, 
1H, NCH), 8.51 (d, 1H, 3JHH = 8.70Hz, Ar–H), 8.18 (d, 1H, 3JHH = 8.40 
Hz, Ar–H), 7.89 (t, 1H, Ar–H), 7.80 (t, 1H, Ar–H), 4.94 (d, 2H, JHH = 7.80 
Hz, CH2), 2.47 (m, 1H, CH), 1.07 (d, 3H, CH3), 1.04 (d, 3H, CH3). 13C 
NMR (75.48 MHz, CDCl3): δ 163.9 (NCS), 141.0, 131.3, 130.9, 129.7, 
126.2, 117.7 (Ar–C), 60.3 (CH2CH(CH3)2), 29.6 (CH2CH(CH3)2), 20.3 
(CH2CH(CH3)2). MS (ESI, positive mode) m/z (%): 192.1 (100) [M – I]+. 
Anal. Calc for C11H14INS: C, 41.39; H, 4.42; N, 4.39. Found: C, 41.39; H, 
4.39; N, 4.33. 
2.4.3 General Procedures for the Preparation of Complexes 2.1–2.6 
A mixture of Ru(RCOO)2(PPh3)2 (0.25 mmol), NaOOCR (0.042 g, 0.5 
mmol) (R = Me, Et) and ligands L1–L3 (0.30 mmol) was stirred under 
vacuum at 50 °C for 1 h. Tetrahydrofuran was then added and the 
suspension refluxed overnight. After cooling, the solvent was removed 
under vacuum, leaving a dull yellow residue, which was re-dissolved in 
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toluene (20 mL) and filtered. The filtrate was mixed with hexane (5 mL) 
and cooled to –20 °C to yield orange-red crystals in 1-2 weeks. 
RuBr(MeCOO)(PPh3)2(N-BzBzTh) (2.1) 
Yield: 0.14 g (0.14 mmol, 56%). 1H NMR (500.1 MHz, CDCl3): δ 
7.47-7.44 (m, 12H, Ar-H), 7.27-7.23 (m, 9H, Ar-H), 7.21-7.13 (m, 13H, 
Ar-H), 6,98 (m, 1H, Ar-H), 6.90 (m, 1H, Ar-H), 6.58 (d, 1H, Ar-H), 6.51 
(m, 2H, Ar-H), 5.58 (s, 2H, CH2), 0.30 (s, 3H, CH3COO). 13C NMR (125.8 
MHz, CDCl3): δ 229.8 (NCS), 184.2 (CH3COO), 143.9, 136.7, 136.5, 135.2, 
135.1, 132.5, 132.4, 132.2, 129.2, 128.7, 127.5, 127.4, 126.8, 126.0, 123.8, 
122.2, 120.0, 112.1 (Ar-C), 53.0 (CH2), 22.2 (CH3COO). 31P NMR (202.4 
MHz, CDCl3): 36.90 (s). Anal. Calc for C52H44BrNO2P2RuS: C, 63.09; H, 
4.48; N, 1.42. Found: C, 63.14; H, 4.71; N, 1.26. 
RuBr(EtCOO)(PPh3)2(N-BzBzTh) (2.2) 
Yield: 0.15 g (0.15 mmol, 61%). 1H NMR (500.1 MHz, CDCl3): δ 
7.47-7.45 (m, 12H, Ar-H), 7.27-7.21 (m, 10H, Ar-H), 7.19-7.14 (m, 12H, 
Ar-H), 6.99 (m, 1H, Ar-H), 6.93 (m, 1H, Ar-H), 6.62 (d, 1H, Ar-H), 6.54 
(m, 2H, Ar-H), 5.62 (s, 2H, CH2), 0.65 (m, 2H, CH3CH2COO), 0.02 (t, 3H, 
CH3CH2COO). 13C NMR (125.8 MHz, CDCl3): δ 230.1 (NCS), 187.0 
(CH3CH2COO), 143.9, 136.8, 136.6, 135.1, 135.0, 132.7, 132.5, 132.4, 
129.1, 128.7, 127.4, 126.8, 126.0, 123.8, 122.2, 120.0, 112.0 (Ar-C), 53.0 
(CH2), 29.4 (CH3CH2COO), 7.8 (CH3CH2COO). 31P NMR (202.4 MHz, 
CDCl3): 36.69 (s). Anal. Calc for C53H46BrNO2P2RuS: C, 63.41; H, 4.62; N, 
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1.39. Found: C, 63.73; H, 4.56; N, 1.34. 
RuI(MeCOO)(PPh3)2(N-PriBzTh) (2.3) 
Yield: 0.10 g (0.10 mmol, 40%). 1H NMR (500.1 MHz, CDCl3): δ 
7.57-7.56 (m, 13H, Ar-H), 7.44 (d, 1H, Ar-H), 7.28, 7.21-7.14 (m, 18H, 
Ar-H), 7.09 (t, 1H, Ar-H), 7.03 (t, 1H, Ar-H), 5.70 (m, 1H, CH(CH3)2), 
1.27 (d, 6H, CH(CH3)2), 0.50 (s, 3H, CH3COO). 13C NMR (125.8 MHz, 
CDCl3): δ 226.0 (NCS), 184.5 (CH3COO), 142.4, 139.5, 135.4, 135.3, 
135.0, 133.6, 133.5, 133.3, 129.2, 127.5, 127.4, 123.3, 121.8, 120.2, 112.8 
(Ar-C), 53.7 (CH(CH3)2), 23.0 (CH3COO), 20.8 (CH(CH3)2). 31P NMR 
(202.4 MHz, CDCl3): 37.28 (s). Anal. Calc for C48H44INO2P2RuS: C, 58.30; 
H, 4.48; N, 1.42. Found: C, 57.97; H, 4.52; N, 1.20. 
RuI(EtCOO)(PPh3)2(N-PriBzTh) (2.4) 
Yield: 0.11 g (0.11 mmol, 45%). 1H NMR (500.1 MHz, CDCl3): δ 
7.58-7.51 (m, 13H, Ar-H), 7.45 (d, 1H, Ar-H), 7.28-7.26 (m, 4H, Ar-H), 
7.21-7.18 (m, 13H, Ar-H), 7.14 (d, 1H, 3JHH = 7.55 Hz, Ar-H), 7.10 (t, 1H, 
Ar-H), 7.03 (t, 1H, Ar-H), 5.78 (m, 1H, CH(CH3)2), 1.27 (d, 6H, 
CH(CH3)2), 0.83 (m, 2H, CH3CH2COO), 0.08 (t, 3H, CH3CH2COO). 13C 
NMR (125.8 MHz, CDCl3): δ 226.6 (NCS), 187.2 (CH3CH2COO), 142.5, 
139.5, 137.8, 136.1, 135.4, 135.3, 133.8, 133.6, 133.5, 129.2, 129.1, 127.4, 
127.3, 121.2, 120.2, 112.7 (Ar-C), 54.0 (CH(CH3)2), 30.0 (CH3CH2COO), 
20.1 (CH(CH3)2), 7.7 (CH3CH2COO). 31P NMR (202.4 MHz, CDCl3): 
37.17 (s). Anal. Calc for C49H46INO2P2RuS: C, 58.68; H, 4.62; N, 1.40. 
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Found: C, 58.71; H, 4.74; N, 1.49. 
RuI(MeCOO)(PPh3)2(N-BuiBzTh) (2.5) 
Yield: 0.13 g (0.13 mmol, 52%). 1H NMR (500.1 MHz, CDCl3): δ 
7.60-7.56 (m, 12H, Ar-H), 7.24-7.15 (m, 19H, Ar-H), 7.09-7.01 (m, 3H, 
Ar-H), 4.02 (d, 2H, 3JHH = 6.95 Hz, CH2CH(CH3)2), 1.85 (m, 1H, 
CH2CH(CH3)2), 0.87 (s, 3H, CH3COO), 0.67 (d, 6H, 3JHH = 6.95 Hz, 
CH2CH(CH3)2). 13C NMR (125.8 MHz, CDCl3): δ 227.3 (NCS), 184.8 
(CH3COO), 144.8, 137.7, 135.6, 135.2, 135.1, 133.7, 133.6, 133.4, 129.3, 
129.0, 127.5, 127.3, 127.2, 123.5, 122.1, 122.0, 111.6 (Ar-C), 55.7 
(CH2CH(CH3)2), 29.4 (CH2CH(CH3)2), 24.0 (CH3COO), 20.4 
(CH2CH(CH3)2). 31P NMR (202.4 MHz, CDCl3): 35.21 (s). Anal. Calc for 
C49H46INO2P2RuS: C, 58.68; H, 4.62; N, 1.40. Found: C, 58.45; H, 4.52; N, 
1.41. 
RuI(EtCOO)(PPh3)2(N-BuiBzTh) (2.6) 
Yield: 0.14 g (0.14 mmol, 56%). 1H NMR (500.1 MHz, CDCl3): δ 
7.60-7.57 (m, 12H, Ar-H), 7.24-7.14 (m, 18H, Ar-H), 7.10-7.01 (m, 4H, 
Ar-H), 4.04 (d, 2H, 3JHH = 7.55 Hz, CH2CH(CH3)2), 1.96 (m, 1H, 
CH2CH(CH3)2), 1.24 (m, 2H, CH3CH2COO), 0.69 (d, 6H, 3JHH = 6.30 Hz, 
CH2CH(CH3)2), 0.34 (t, 3H, CH3CH2COO). 13C NMR (125.8 MHz, CDCl3): 
δ 227.7 (NCS), 187.6 (CH3CH2COO), 144.8, 137.7, 135.6, 135.2, 135.1, 
134.8, 133.9, 133.8, 133.6, 129.2, 129.0, 127.4, 127.3, 127.2, 123.4, 122.0, 
119.7, 111.6 (Ar-C), 55.8 (CH2CH(CH3)2), 30.7 (CH3CH2COO), 29.2 
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(CH2CH(CH3)2), 20.4 (CH2CH(CH3)2), 7.9 (CH3CH2COO). 31P NMR 
(202.4 MHz, CDCl3): 35.22 (s). Anal. Calc for C50H48INO2P2RuS: C, 59.05; 
H, 4.76; N, 1.38. Found: C, 59.10; H, 5.08; N, 1.39. 
2.4.4 General Procedure for the Transfer Hydrogenation Reaction 
The transfer hydrogenation experiments were carried out using standard 
Schlenk techniques. A mixture of appropriate amount of ruthenium 
complexes 2.1–2.6 (1 mol %), and the ketone (1 mmol) was dissolved in 
2-propanol (20 mL). The solution was heated to 82 °C. When 0.1 M 
NaOBut (1 mL) was added, the reaction commenced immediately. After 
refluxing for about 30 h, the reaction mixture was directly passed through a 
pad of silica gel with Et2O. The crude product was collected for GC-Mass 
chromatography analysis. 
2.4.5 X-Ray Diffraction Studies 
Suitable crystals were mounted on quartz fibers and X-ray data were 
collected on a Bruker AXS APEX diffractometer equipped with a CCD 
detector, using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). 
The data were corrected for Lorentz and polarization effects with the 
SMART program suite and for absorption effects with SADABS. The 
crystal structures were solved by direct methods and refined by full-matrix 
least squares on F2 using the SHELXTL program package. In complex 2.1, 
one of the toluene solvates lies on the inversion center and adopts a higher 
symmetry than the overall molecule. Such higher symmetry is supressed in 
the refinement and the toluene molecule is treated by the disordered model 
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with the occupancy factors of  its atoms fixed at 0.5 each. In 2.6, the 
isobutyl group adopts a positional disorder and the ratio of the two 
disordered components were refined to be 0.46/0.64. All non-hydrogen 
atoms were refined anisotropically. Hydrogen atoms were calculated in 
ideal geometries and refined isotropically. Selected crystal data for 
complexes 2.1–2.6 are summarized in Table 2.4. 
 
Table 2.4 Summary of crystallographic parameters and refinement results for 
complexes 2.1–2.6 






fw 1128.06 1003.89 1080.95 
cryst. Syst. Triclinic Monoclinic Monoclinic 
space group P-1 P2(1)/c P2(1)/c 
a (Å) 11.359(4) 9.9427(4) 17.0266(6) 
b (Å) 14.753(5) 24.157(1) 15.0002(6) 
c (Å) 17.270(6) 18.7354(7) 20.3236(7) 
α (°) 93.390(9) 90 90 
β (°) 104.451(8) 95.813 (1) 110.539(1) 
γ (°) 107.96(1) 90 90 
V (Å3) 2636.8(15) 4476.8(3) 4860.7(3) 
Z 2 4 4 
Dcalcd (g·cm–3) 1.421 1.489 1.477 
μ (mm–1) 1.201 1.404 1.109 
F(000) 1158 2048 2192 
no. of reflns collected 28965 31658 57081 
no. of unique reflns 9311 10257 11151 
Rint 0.1091 0.0605 0.0357 
no. of observed reflns 6098 7837 10310 
parameters 607 551 572 
T (K) 293(2) 223(2) 223(2) 
R1a (all data) 0.1148 0.0652 0.0420 
wR2b(all data) 0.1570 0.1075 0.0861 
GOFc 1.017 0.991 1.127 
Δρmax (e Å–3) 0.883 1.268 0.798 
Δρmin (e Å–3) –0.634 –0.381 –0.624 
    
 2.4 2.5 2.6 
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fw 1186.10 1002.84 1016.86 
cryst. Syst. Triclinic Triclinic Triclinic 
space group P-1 P-1 P-1 
a (Å) 10.7883(5) 11.1382(5) 11.540 (2) 
b (Å) 13.8789(7) 12.3698(6) 12.354(2) 
c (Å) 18.6293(9) 18.7464(8) 17.615(3) 
α (°) 90.848(1) 74.524(1) 72.444(2) 
β (°) 94.240(1) 81.573(1) 76.977(2) 
γ (°) 96.860(1) 63.401(1) 69.123(2) 
V (Å3) 2761.0(2) 2224.6(2) 2217.4(5) 
Z 2 2 2 
Dcalcd (g·cm–3) 1.427 1.497 1.523 
μ (mm–1) 0.983 1.205 1.210 
F(000) 1210 1012 1028 
no. of reflns collected 35988 28984 28850 
no. of unique reflns 12643 10201 10157 
Rint 0.0315 0.0311 0.0272 
no. of observed reflns 11067 9528 9304 
parameters 645 517 548 
T (K) 223(2) 223(2) 223(2) 
R1a (all data) 0.0417 0.0270 0.0300 
wR2b(all data) 0.0931 0.0611 0.0658 
GOFc 1.082 1.049 1.041 
Δρmax (e Å–3) 1.088 0.638 0.618 
Δρmin (e Å–3) –0.399 –0.0611 –0.0658 
    
a R1 = Σ||Fo|-|Fc||/Σ|Fo|. b wR2 = {wΣ(|Fo|-|Fc|)2/Σw|Fo|2}}1/2. c GOF = {Σw(|Fo|-|Fc|)2/(n-p)}1/2, 
where n is the number of reflections and p is total number of parameters refined. 
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Chapter 3 Syntheses and Structures of Ruthenium(II) 
N,S-Heterocyclic Carbene Diphosphine Complexes and 




Ruthenium N-heterocyclic carbene (NHC) complexes are known for 
functional group tolerance and robustness under standard organic synthetic 
conditions.80,103,133,136-137,160,171-180 One of the general design principles of 
active Ru-NHC complexes requires the disposition of a labile functionality 
trans to carbene.26,181-182 Prominent examples include the Grubbs 2nd 
generation olefin metathesis catalysts that contain coordinated 
tricyclohexylphosphine (PCy3).21 Chelated alkylidenes,183-187 bidentate Schiff 
base ligand,188-189 P,O- and N,O- chelates190-193 have been introduced to 
improve the thermal, oxygen and moisture tolerance. Somewhat surprising is 
the lack of bidentate phosphine ligands among the known Ru-NHC 
catalysts86,88,194 although ruthenium diphosphine complexes have proven to be 
effective towards a wide range of organic transformations.27,195-201 It is hence 
important to develop a facile synthetic methodology for Ru(II) 
NHC-diphosphine complexes for catalysis. In this chapter, we will discuss a 
general synthetic pathway for mixed-ligand complexes 
RuIIBr(MeCOO)(3-RBzTh)(η2-P2) (3-RBzTh = 
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3-benzylbenzothiazol-2-ylidene; P2 = chelating diphosphine) and their 
catalytic activities towards transfer hydrogenation. 
 
3.2 Results and Discussion 
3.2.1 Synthesis and Characterization of Complexes 3.1–3.5 
Diphosphine substitutions of RuIIBr(MeCOO)(3-RBzTh)(PPh3)2 (3-RBzTh = 
3-benzylbenzothiazol-2-ylidene) (2.1)202 by bis(diphenylphosphino)methane 
(dppm), 1,2-bis(diphenylphosphino)ethylene (dppv), 
1,1’-bis(diphenylphosphino)ferrocene (dppf), 
1,4-bis(diphenylphosphino)butane (dppb) and 
1,3-(diphenylphosphino)propane (dppp) give new complexes 
RuBr(MeCOO)(3-RBzTh)(η2-P2) (P2 = dppm (3.1), dppv (3.2), dppf (3.3), 
dppb (3.4), dppp (3.5a, 3.5b) in moderate to high yields (61–95%) (Scheme 
3.1). Complexes 3.1–3.5 are readily soluble in CH2Cl2, THF and toluene and 
slightly soluble in Et2O. All products have been characterized by ESI spectral 
analysis. In chapter 2, we have demonstrated that Ru(MeCOO)2(PPh3)2 
bearing two carboxyl groups could be used as a versatile precursor for a series 
ruthenium mono-NSHC complexes such as complex 2.1. Thus, complexes 
3.1–3.5a may also be prepared from phosphine substitution with the precursor 
Ru(MeCOO)2(PPh3)2, giving Ru(MeCOO)2(η2-P2),203 followed by acid 
condensation with benzothiazolium salt. This alternative synthesis is 
exemplified by the successful preparation of 3.1 and 3.4 from the one-pot 
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condensation reaction between Ru(MeCOO)2(η2-P2) and 
N-benzylbenzothiazolium bromide [(C6H4)SCHNR]X (R and X = benzyl and 
Br) in the presence of NaOAc. 
 
Scheme 3.1. Synthetic route of Ru(II)-(benzothiazol-2-ylidene) complexes 3.1–3.5 
 
3.2.2 NMR Studies of Complexes 3.1 to 3.5 
The 31P NMR spectra of 3.1–3.5 show downfield shift, thus pointing to 
successful coordination of both phosphine sites in all cases. The most 
notable contrast with 2.1 is the presence of two discrete 31P resonances, 
implying cis-orientation of a chelating diphosphine with different trans 
ligands across the phosphine donors. This rules out a symmetrical bridge 
formation or a trans orientation as occurred in 2.1. The phosphine 
inequivalence and restricted rotation of the Ru-C bond differentiate the two 
CH2 protons of the benzyl substituent. 
The 31P NMR spectrum of the reaction mixture of 2.1 and dppp at r.t. is unique 
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in showing a mixture of products that are consistent with geometric isomers 
3.5a and 3.5b. Both show mutually-coupled inequivalent phosphines (3.5a: δ 
40.5 and 45.7 ppm for the phosphorus donors trans to bromide and oxygen; 
3.5b: δ 14.6 and 54.2 ppm for phosphorus trans to carbene and oxygen 
respectively). Under THF reflux conditions, 3.5a is formed and isolated in 
pure form. Complex 3.5b is formed at r.t. but cannot be isolated free of 3.5a. 
Its 31P NMR is fluxional, probably through an inter-converting process of 
diastereomeric isomers in solution. Upon cooling from r.t. to –20 °C, the broad 
31P resonance sharpens and then well resolved into a pair of anticipated 
doublets (2JPP 40 Hz) (Figure 3.1). Its solution slowly changes from red to 
bright yellow at r.t.. Its 31P NMR spectrum accordingly suggests the 
conversion of 3.5b (31P NMR: δ 54.2 and 14.6 ppm) to 3.5a (31P NMR: δ 45.7 
and 40.5 ppm) within 66 h at r.t.. (Figure 3.2) Complex 3.5b is hence 
concluded to be a kinetic product in a reaction that drives towards 3.5a as the 
thermodynamic outcome. Complexes 3.1–3.5 (except 3.5b) are stable in both 










Figure 3.1. VT 31P NMR spectroscopic study of complex 3.5b 
 
 
Figure 3.2. 31P NMR spectroscopic study of complex 3.5a and 3.5b at r.t. 
 
3.2.3 Molecular Structures of Complexes 3.1–3.5 











elucidated by single-crystal X-ray diffraction studies. (Figure 3.3) They are 
universally mononuclear and neutral, showing an octahedral ruthenium sphere 
with four different ligands, namely, a chelating diphosphine, carboxylate, 
NSHC carbene and bromide. They can be categorized into two structural types, 
I and II, based on the relative dispositions of the ligands. Type I structures 
contain a carbenic carbon trans to the oxygen whereas two phosphorus atoms 
are trans to Br and O. Type II system comprises a carbene carbon trans to one 
of the P atoms whereas the other P is trans to O, with Br trans to the 
remaining O. Complexes 3.1, 3.2, 3.3 and 3.5a belong to Type I, whereas 3.4 
and 3.5b are Type II category (Scheme 3.1). The former, with phosphine 
avoiding facing a high trans-ligand carbene, is more common and generally 
expected. Although complex 3.4 shares the same structural type as 3.5b, it is 
thermodynamically stable and does not convert to Type I isomer under the 
present experimental conditions. 
 
       
3.1                                 3.2 
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3.3                                   3.4 
         
3.5a                                   3.5b 
Figure 3.3. Ortep diagrams of the structures of 3.1–3.5 with 50% probalility ellipsoids 
and labelling scheme, the hydrogen atoms and solvent molecule were omitted for clarity. 
 
It is remarkable that these diphosphines with a diverse range of spacer 
lengths and skeletal properties have adapted to a common mononuclear core 
as chelating ligands, especially considering that ligands such as dppf204 and 
dppb could easily adopt the bridging mode. This is exemplified by the 
tolerance over a wide span of ∠P-Ru-P angles (73.05(3)-101.16(7)°) and P…P 
distances (2.669-3.578 Å). (Table 3.1) The metallo-diphosphine ring 
properties have been related to the catalytic behaviors of some 
systems.27,149,195-201,204-209 The Ru-C bonds (1.957(7)–2.034(6) Å) for 3.1–3.5 
are within the range reported for Ru-NSHC complexes [e.g. complex 2.1 
(1.970(6) Å);202 RuCl2(3-Ph-DMeTh)(=CH-o-iPrO–Ph) (DMeTh = 
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4,5-dimethylthiazol-2-ylidene) (1.944(1) Å);28 [RuF(H)(PPh3)2(CO)(NHC)] 
(NHC = 1,3,4,5-tetramethylimidazol-2-ylidene) (2.170(2) Å);162 mer, 
cis-[RuCl2(CO)(NHC)] (NHC = 
1,3-bis(2-diphenylphosphanylethyl)-3H-imidazol-2-ylidene) (2.038(3) Å)112. 
With carbene and phosphine at mutually trans-orientation,166,168-170,210 Type II 
structures understandably show the longest, and presumably weakest, Ru-C 
(2.056(3) for 3.4 and 2.034(6) Å for 3.5b) and Ru-P bonds (2.3751(9) for 3.4 
and 2.363(2) Å for 3.5b). The acetate chelate is most distorted in 3.5b, 
showing the highest contrast in Ru-O lengths (2.127(4) and 2.242(4) Å), the 
latter is also the weakest Ru-O in this series. These offer a possible 
explanation on the fluxionality of 3.5b. A facile chelate to monodentate 
conversion of the acetate would readily create a fluxional 5-coordinated 
structure that would allow the carbene and bromide to swap positions followed 
by chelate re-formation to give 3.5a. The stability of 3.5a is also exemplified 
by a near-ideal ∠P1-Ru1-P2 chelate angle (92.00(7)°) and strong 2JPP coupling 
(40.9 Hz). 
 
Table 3.1 Selected bond lengths (Å) and angles (°) for 3.1–3.5 
 3.1 3.2 3.3 
Ru(1)-C(1) 1.972(3) 1.980(4) 1.982(7) 
Ru(1)-P(1) 2.2311(9) 2.245(1) 2.335(2) 
Ru(1)-P(2) 2.2529(9) 2.255(1) 2.297(2) 
Ru(1)-Br(1) 2.5792(5) 2.5942( 6) 2.570(1) 
Ru(1)-O(1) 2.214(2) 2.217(3) 2.200(5) 
Ru(1)-O(2) 2.186(2) 2.205(3) 2.200(5) 
P(1)…P(2) 2.669 3.023 3.578 
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P(1)-Ru(1)-P(2) 73.05(3) 84.38(4) 101.16(7) 
O(1)-Ru(1)-O(2) 59.51(8) 59.1(1) 59.6(2) 
C(1)-Ru(1)-P(1) 95.75(9) 93.3(1) 89.7(2) 
C(1)-Ru(1)-P(2) 90.37(9) 88.8(1) 97.0(2) 
Br(1)-Ru(1)-P(1) 98.53(3) 95.71(3) 169.52(5) 
Br(1)-Ru(1)-P(2) 170.61(2) 173.36(3) 89.25(6) 
Dihedral anglea 28.4 31.9 32.3 
    
 3.4 3.5a 3.5b 
Ru(1)-C(1) 2.056(3) 1.957(7) 2.034(6) 
Ru(1)-P(1) 2.3751(9) 2.283(2) 2.363(2) 
Ru(1)-P(2) 2.2580(9) 2.280(2) 2.236(1) 
Ru(1)-Br(1) 2.5530(4) 2.6025(9) 2.5434(7) 
Ru(1)-O(1) 2.226(2) 2.219(5) 2.127(4) 
Ru(1)-O(2) 2.135(2) 2.182(5) 2.242(4) 
P(1)…P(2) 3.429 3.282 3.322 
    
P(1)-Ru(1)-P(2) 95.46(3) 92.00(7) 92.45(5) 
O(1)-Ru(1)-O(2) 59.84(9) 59.8(2) 59.8(2) 
C(1)-Ru(1)-P(1) 174.77(9) 93.8(2) 173.6(2) 
C(1)-Ru(1)-P(2) 89.75(9) 94.2(2) 92.9(2) 
Br(1)-Ru(1)-P(1) 90.76(2) 89.86(5) 85.95(4) 
Br(1)-Ru(1)-P(2) 89.47(2) 171.63(5) 87.79(4) 
Dihedral anglea 18.8 42.1 23.7 
    
a dihedral angle between the N,S-heterocyclic carbene ring and coordination plane. 
 
It is of interest to notice that in each complex the carbene ring rotates to a 
certain degree with respect to the Ru-C bond. The heterocylic ring of the 
carbene tends to rotate out of the coordination plane (by 18.8°-42.1° in 3.1-3.5) 
to accommodate other secondary intra- and intermolecular interactions. 
(Figure 3.4) In 3.1, the rotation (28.4°) is accompanied by intramolecular 
C-H···O hydrogen bonding (C8···O1 3.03 Å; C8-H8B···O1 138.9°) and 
intermolecular offset π–π interaction (3.35 Å) between the heterocyclic ring 
and its symmetry-generated counterpart (–x, –y+1, –z+1). (Figure 3.4) In 3.2, 
similar C-H···O hydrogen bonding (C8···O2 3.03 Å; C8-H8B···O2 135.1°) is 
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evident except that the rotation increases to 31.9° to alleviate the close 
contacts between the γ-H on the nitrogen substituent and the protons on the 
neighboring phenyl rings of dppv (H8A···H2C 2.84 Å). In 3.3, the rotation 
rises further to 32.3° to accommodate the C-H···O hydrogen bonding (C8···O2 
3.03 Å; C8-H8A···O2 141.6°), non-bonding H···H contact (H8B···H6B 2.48 Å) 
and additional intramolecular face-to-face π–π interaction between the 
5-membered C1-S1-C7-C2-N1 and 6-membered 
C1B-C2B-C3B-C4B-C5B-C6B (3.45 Å between ring centroids) rings. In 3.4, 
the intramolecular C-H···O hydrogen bonding (C8···O2 2.89 Å; C8-H8B···O2 
121.1°) and the intramolecular face-to-face π–π interaction between the 
5-membered C1-S1-C7-C2-N1 and 6-membered 
C1C-C2C-C3C-C4C-C5C-C6C (3.62 Å between ring centroids) rings possibly 
governs the carbene ring rotation (18.8°). The large ring rotation in 3.5a (42.1°) 
is traced to an edge-to-face C-H···π interaction between a pair of C-H bonds of 
the phenyl ring of the nitrogen substituent and C=C bond of the phenyl ring of 
dppp (H10···C6D 2.92 Å, C10-H10···C6D 153.1°; H11···C5D 3.32 Å, 
C11-H11···C5D 129.9°) and the intramolecular C-H···O hydrogen bonding 
(C8···O2 3.23 Å; C8-H8A···O2 135.6°). Complex 3.5b shows intermolecular 
hydrogen bonding within each pair of molecules. The ring rotates 23.7° out of 
the coordination plane to minimize interactions between the phenyl ring of the 
nitrogen substituent C13-H13 or C14-H14 and O2A (C13···O2A 3.19 Å; 
C13-H13A···O2A 123.9°; C14···O2A 3.24 Å; C14-H14A···O2A 118.2°; 
68 
















Figure 3.4. Ortep diagrams of 3.1–3.5 showing their inter- or intra-molecular 
interactions 
 
3.2.4 Transfer Hydrogenation 
The catalytic performance of 3.1–3.5 towards the reduction of p-methyl 
acetophenone by 2-propanol to 1-(4-methylphenyl)ethanol has been compared. 
(Table 3.2) Complex 3.1 generally gives the best yields within 24 h at a 
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catalyst load of 1 mol%. This is consistent with the strength of the carbene and 
diphosphine chelate, as 3.1 has the strongest Ru-C and Ru-P bonds in this 
series. As this form of transfer hydrogenation typically goes through a hydride 
intermediate and the bromide-hydride exchange is expected to be facile, the 
stability of the [Ru(NSHC)(PP)] core could be a determining factor. Complex 
3.1 has a slight advantage over its precursor 2.1, which returns with a similarly 
yield of ~90% but requires a longer reaction duration. 
 
Table 3.2. Catalytic Transfer Hydrogenation of p-Methyl Acetophenone with 
Complexes 3.1–3.5 
 
Entry Catalyst Time (h) Yield (%) 
1 3.1 8 57 
2 3.1 12 68 
3 3.1 24 90 
4 2.1 30 91 
5 3.2 24 52 
6 3.3 24 46 
7 3.4 24 68 
8 3.5a 24 48 
9 3.5b 24 32 
    
Experimental Conditions: ketone, 1 mmol; NaOBut, 0.1 mmol; 
Catalyst, 0.01 mmol; 2-propanol, 15 mL; temp, 82°C.  
 
Complex 3.1 was thus chosen to compare its effect on different alkyl and aryl 
ketones. (Table 3.3). It returns with excellent yields (91-97%) except towards 
benzophenone and 4-methoxyacetophenone (Entry 5 and 6), which could be 
attributed to unfavorable electronic (Entry 5) and steric effects (Entry 6) of the 
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substituent on the ketones. These are comparable with the performance of 
2.1.202 Use of phosphine-free NHC complexes107,112-113,154,156,211-212 such as 
[Ru(NO)(L)Cl3] (L = 3-tert-butyl-1-(2-pyridyl)imidazol-2-ylidene) provides 
an alternative with similar yield (96%) in similar reduction of acetophenone 
but within a shorter period of 4 h. There are other effective carbene-free 
catalysts that are supported by [NNN] or [PNN] tridentate ligands.150,153,213-214 
 
Table 3.3. Catalytic Transfer Hydrogenation of ketones 
with Complexes 3.1 
 
Entry Substrate Product Yield (%) 
1 cyclopentanone Cyclopentanol 95 
2 acetophenone 1-phenylethanol 91 
3 4-chloroacetophenone 1-(4-chlorophenyl)ethanol 94 
4 4-bromoacetophenone 1-(4-bromophenyl)ethanol 97 
5 4-methoxyacetophenone 1-(4-methoxyphenyl)ethanol 8 
6 benzophenone diphenylmethanol 12 
    
Experimental Conditions: ketone, 1 mmol; NaOBut, 0.1 mmol; Catalyst, 0.01 
mmol; 2-propanol, 15 mL; temp, 82°C. 
 
3.3 Summary 
We have developed a convenient synthetic method to Ru(II) complexes with 
all-different ligands. The formulation of these complexes are based on two 
stable and non-dissociative (viz. NSHC carbene and diphosphine) and two 
dissociative and exchangeable (viz. bromide and acetate) ligands. This unique 
combination would potentially create a plethora of new Ru(II) catalysts based 
on interaction of the robust [Ru(P-P)(NSHC)] core with a wide range of 
anions, substrates, and reactive species. Another option is to introduce 
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chelating carbene, or dicarbene, which has been shown to be effective in 
catalytic transfer hydrogenation, to this core.107,112-113,154,156,211-212 We are 
exploring the catalytic potential of this new system with reference to the rich 
catalytic chemistry that has been established for the [RuII(PR3)2-3] 
system.27,111,133-134,148-149,153,165,195-201,215 A distinctive feature of this 
diphosphine-carbene combination is that, as demonstrated in the isolation of 
3.4 and 3.5b, alternative geometric isomers can be stabilized through 
adjustment of the skeletal traits of the diphsophine. Such stereochemical 
tuning, which is lacking among monodentate phosphines, offers a simple 
mechanism to examine the stereo-geometrical effect on catalytic efficacy.  
 
3.4 Experimental Section 
3.4.1 General Procedures and Materials 
All manipulations were carried out under a dry nitrogen atmosphere using 
standard Schlenk techniques. Complex 2.1 was prepared according to the 
method reported in chapter 2. Other commercially available chemicals were 
purchased from Sigma-Aldrich. All solvents were freshly distilled from 
standard drying agents. 1H (500.1 MHz), 31P (202.4 MHz) and 13C(125.8 MHz) 
NMR spectra were recorded in ppm on a Bruker AMX 500 spectrometer. The 
chemical shifts (δ) are referenced to TMS for 1H and 13C{1H} and H3PO4(85%) 
for 31P{1H}. ESI mass spectra were obtained using a Finnigan LCQ. Elemental 
analyses were performed on a Perkin-Elmer PE 2400 elemental analyzer. The 
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yields of transfer hydrogenation products were determined by using Hewlett 
Packard Series 6890 GC (Santa Clara, CA, USA) coupled to a Hewlett 
Packard 5973 MS detector. 
3.4.2 General Procedures for the Preparation of 
RuBr(MeCOO)(3-RBzTh)(η2-P2) (3-RBzTh = 3-benzyl 
benzothiazol-2-ylidene; P2 = dppm (3.1), dppv (3.2), dppf (3.3), dppb (3.4), 
dppp (3.5a and 3.5b)) complexes (3.1–3.5) 
A mixture of Ru(3-RBzTh)(PPh3)2(CH3COO)2Br 2.1 (0.198 g, 0.20 mmol) 
and diphosphorus ligands (0.22 mmol) was suspended in THF. The 
resultant orange solution was refluxed (3.1–3.4 and 3.5a) or stirred at r.t. 
(3.5b) for 3 h. Upon cooling, the solvent was removed under vacuum, 
leaving the yellow or orange residue, which was then washed several times 
with hexane. The powder product was re-dissolved in CH2Cl2 and diffused 
with hexane. The yellow to orange crystals of 3.1–3.5 were obtained within 
a week. 
RuBr(MeCOO)(3-RBzTh)(η2-dppm) (3.1) 
Yield: 0.16 g (0.19 mmol, 94%). 1H NMR (CDCl3): δ 8.25-8.22 (m, 2H, 
Ar-H), 8.13-8.09 (m, 2H, Ar-H), 7.48-7.32 (m, 10H, Ar-H), 7.29-7.07 (m, 
10H, Ar-H), 7.07-6.94 (m, 3H, Ar-H), 6.74 (d, 1H, 2JHH = 16.4 Hz,CH2), 
6.31 (d, 1H, 2JHH = 16.4 Hz,CH2), 5.22 (m, 1H, 2JPH = 15.1 and 10.4 Hz, 
2JHH = 10.7 Hz, PCH2P), 4.93 (m, 1H, 2JPH = 14.5 and 10.7 Hz, 2JHH = 10.7 
Hz, PCH2P), 1.53 (s, 1H, CH3COO). 13C NMR (CDCl3): δ 231.0 (NCS), 
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186.1 (CH3COO), 137.3, 136.2, 136.0, 134.2, 133.9, 133.3, 133.0, 132.9, 
132.2, 132.1, 132.0, 131.9, 130.2, 130.1, 129.6, 128.7, 128.6, 128.2, 127.7, 
127.0 (Ar-C), 125.1, 122.8, 119.6, 113.7 (Ar-Cmeta/ortho, N/S), 56.4 (CH2), 
51.0 (JPC = 23.0 Hz, PCH2P), 24.6 (CH3COO). 31P NMR (CDCl3): δ 14.2, 
11.2 (d, JPP = 78.1 Hz). MS (ESI, positive mode) m/z (%): 770.03 (100) [M 
– Br]+. Anal. Calc for C41H36BrNO2P2RuS: C, 57.95; H, 4.27; N, 1.65. 
Found: C, 57.71; H, 4.15; N, 1.64. 
RuBr(MeCOO)(3-RBzTh)(η2-dppv) (3.2) 
Yield: 0.15 g (0.17 mmol, 87%). 1H NMR (CDCl3): δ 8.30-8.21 (m, 3H, 
Ar-H), 7.96-7.78 (m, 3H, Ar-H), 7.57-7.47 (m, 1H, Ar-H; 1H, CH=CH; 1H, 
CH2), 7.36-7.19 (m, 14H, Ar-H), 7.12-7.09 (m, 2H, Ar-H), 7.02-6.95 (m, 
2H, Ar-H; 1H, CH=CH), 6.93-6.87 (m, 2H, Ar-H), 6.83-6.79 (m, 1H, Ar-H), 
5.76 (d, 1H, 2JHH = 16.4 Hz, CH2), 1.37 (t, 3H, CH3COO). 13C NMR 
(CDCl3): δ 229.0 (NCS), 186.1 (CH3COO), 153.2 (JCP = 26.9 and 27.9 Hz, 
CH=CH), 145.3 (JCP = 24.9 and 23.9 Hz, CH=CH), 144.3, 137.6, 136.1, 
135.7, 134.5, 134.4, 133.7, 133.3, 133.1, 133.0, 132.6, 132.4, 132.3, 132.2, 
132.0, 131.8, 130.2, 129.8. 129.6, 128.5, 128.3, 128.2, 128.1, 128.0, 127.9, 
127.8, 127.0 (Ar-C), 124.7, 122.5, 119.2, 113.4 (Ar-Cmeta/ortho, N/S), 56.6 
(CH2), 24.6 (CH3COO). 31P NMR (CDCl3): δ 87.5, 84.9 (d, JPP = 13.6 Hz). 
MS (ESI, positive mode) m/z (%): 782.03 (100) [M – Br]+. Anal. Calc for 
C42H36BrNO2P2RuS: C, 58.54; H, 4.21; N, 1.62. Found: C, 58.11; H, 
4.15; N, 1.60. 
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RuBr(MeCOO)(3-RBzTh)(η2-dppf) (3.3) 
Yield: 0.16 g (0.17 mmol, 83%). 1H NMR (CDCl3): δ 8.02 (m, 2H, Ar-H), 
7.84 (m, 2H, Ar-H), 7.61 (m, 2H, Ar-H), 7.29-7.27 (m, 7H, Ar-H), 
7.24-7.17 (m, 5H, Ar-H), 7.15-7.09 (m, 5H, Ar-H), 7.04-7.01 (m, 1H, Ar-H; 
1H, CH2), 6.98-6.94 (m, 5H, Ar-H), 6.13 (d, 1H, 2JHH = 16.4 Hz, CH2), 
5.08 (s, 1H, Cp-H), 4.79 (m, 2H, Cp-H), 4.46 (m, 2H, Cp-H), 4.36 (m, 3H, 
Cp-H), 1.14 (s, 3H, CH3COO). 13C NMR (CDCl3): δ 230.2 (JCP = 14.0 and 
13.0 Hz, NCS), 186.6 (CH3COO), 145.0, 139.6, 139.2, 138.0, 136.4, 136.1, 
135.8, 134.8, 134.5, 134.4, 134.3, 134.2, 134.1, 133.6, 133.5, 129.3, 128.9, 
128.7, 128.1, 127.6, 127.2, 127.1, 127.0, 126.8 (Ar-C), 124.8, 122.7, 119.1, 
113.5 (Ar-Cmeta/ortho, N/S), 76.8-77.3 (Cp-C, overlapping singlets), 76.5 (d, 
JCP = 12.0 Hz, Cp-C), 75.8 (d, JCP = 10.0 Hz, Cp-C), 75.5 (dd, JCP = 8.6 and 
7.3 Hz, Cp-C), 72.2 (d, JCP = 6.0 Hz, Cp-C), 72.0 (d, JCP = 7.0 Hz, Cp-C), 
71.7(d, JCP = 6.0 Hz, Cp-C), 70.5 (d, JCP = 5.0 Hz, Cp-C), 56.0 (CH2), 24.4 
(CH3COO). 31P NMR (CDCl3): δ 49.4, 47.6 (d, JPP = 24.8 Hz). MS (ESI, 
positive mode) m/z (%): 940.09 (100) [M – Br]+. Anal. Calc for 
C50H42BrFeNO2P2RuS: C, 58.89; H, 4.15; N, 1.37. Found: C, 58.89; H, 
4.14; N, 1.48. 
RuBr(MeCOO)(3-RBzTh)(η2-dppb) (3.4) 
Yield: 0.17 g (0.19 mmol, 95%). 1H NMR (CDCl3): δ 8.31-8.27 (m, 2H, 
Ar-H), 7.99-7.96 (m, 2H, Ar-H), 7.58-7.55 (m, 2H, Ar-H), 7.38-7.29 (m, 
8H, Ar-H; 1H, CH2), 7.23 (m, 3H, Ar-H), 7.15-7.03 (m, 6H, Ar-H), 
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6.89-6.81 (m, 5H, Ar-H), 6.64 (d, 1H, JHH = 8.2 Hz, Ar-H), 4.56 (d, 1H, JHH 
= 4.0 Hz, CH2), 2.95 (m, 1H, CH2(CH2)2CH2), 2.81 (m, 1H, 
CH2(CH2)2CH2), 2.68-2.61 (m, 2H, CH2(CH2)2CH2), 2.14 (m, 1H, 
CH2(CH2)2CH2), 2.06-1.94 (m, 2H, CH2(CH2)2CH2), 1.69 (m, 1H, 
CH2(CH2)2CH2), 1.46 (s, 3H, CH3COO). 13C NMR (CDCl3): δ 229.0 (JCP = 
14.9 and 13.0 Hz, NCS), 186.2 (CH3COO), 144.5, 139.2, 138.9, 137.9, 
137.5, 135.7, 135.3, 135.1, 134.8, 134.4, 133.8, 132.8, 132.6, 131.7, 129.4, 
129.2, 129.0, 128.2, 127.9, 127.7, 127.5, 126.9 (Ar-C), 124.5, 122.4, 118.7, 
113.5 (Ar-Cmeta/ortho, N/S), 56.1 (CH2), 27.3 (JCP = 27.9 Hz, CH2(CH2)2CH2), 
25.1-25.0 (m, overlapping siglets, CH2(CH2)2CH2), CH3COO), 22.8 
(CH2(CH2)2CH2), 20.6 CH2(CH2)2CH2). 31P NMR (CDCl3): δ 53.4, 37.3 (d, 
JPP = 28.5 Hz). MS (ESI, positive mode) m/z (%): 812.11 (100) [M – Br]+. 
Anal. Calc for C44H42BrNO2P2RuS: C, 59.26; H, 4.75; N, 1.57. Found: C, 
59.26; H, 4.82; N, 1.70. 
RuBr(MeCOO)(3-RBzTh)(η2-dppp) (3.5a) 
Yield: 0.16 g (0.18 mmol, 91%). 1H NMR (CDCl3): δ 8.06-8.05 (m, 2H, 
Ar-H), 7.85-7.82 (m, 2H, Ar-H), 7.48-7.41 (m, 5H, Ar-H),7.38 (m, 1H, 
Ar-H), 7.30-7.10 (m, 13H, Ar-H), 7.05-6.95 (m, 4H, Ar-H; 1H, CH2), 6.84 
(d, 1H, JHH = 8.2 Hz, Ar-H), 5.16 (d, 1H, JHH = 15.8 Hz, CH2), 3.10-2.99 
(m, 2H, CH2CH2CH2), 2.66-2.60 (m, 2H, CH2CH2CH2), 2.45 (m, 1H, 
CH2CH2CH2), 2.08 (m, 1H, CH2CH2CH2), 1.35 (s, 3H, CH3COO). 13C 
NMR (CDCl3): δ 227.9 (JCP = 14.0 Hz, NCS), 185.2 (CH3COO), 145.0, 
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137.4, 136.4, 136.0, 135.3, 135.2, 135.0, 134.7, 134.3, 134.1, 134.0, 133.3, 
133.2, 131.8, 129.4, 129.3, 129.1, 128.2, 128.0, 127.9, 127.7, 127.6, 127.5, 
127.4, 127.1, 126.7 (Ar-C), 125.0, 122.9, 119.1, 114.0 (Ar-Cmeta/ortho, N/S), 
56.4 (CH2), 29.0 (dd, JCP = 30.9 and 4.0 Hz, CH2CH2CH2), 28.9 (d, JCP = 
32.9, CH2CH2CH2), 24.5 (CH3COO), 20.5 (CH2CH2CH2). 31P NMR 
(CDCl3): δ 45.7, 40.5 (d, JPP = 40.9 Hz). MS (ESI, positive mode) m/z (%): 
797.9 (100) [M – Br]+. Anal. Calc for C43H40BrNO2P2RuS: C, 58.84; H, 
4.59; N, 1.60. Found: C, 58.68; H, 4.97; N, 1.38. 
RuBr(MeCOO)(3-RBzTh)(η2-dppp) (3.5b) 
Yield: 0.11 g (0.12 mmol, 61%). 1H NMR (CDCl3): δ 8.05-8.03 (m, 2H, Ar-H), 
7.69 (d, 1H, Ar-H), 7.45-7.08 (m, 21H, Ar-H),6.82-6.60 (m, 6H, Ar-H), 5.95 (d, 
1H, 2JHH = 15.8 Hz, CH2), 5.86 (d, 1H, JHH = 15.8 Hz, CH2), 3.00 (m, 1H, 
CH2CH2CH2), 2.84-2.77 (m, 2H, CH2CH2CH2), 2.46-2.22 (m, 2H, 
CH2CH2CH2), 1.77 (m, 1H, CH2CH2CH2), 1.06 (s, 3H, CH3COO). 13C NMR 
(CDCl3): δ 185.1 (CH3COO), 144.3, 137.3, 136.8, 136.2, 135.9, 134.9, 134.8, 
134.3, 134.1, 134.0, 133.3, 130.2, 129.9, 129.1, 128.4, 127.9, 127.8, 127.7, 
127.6, 127.4, 126.8, 126.7, 125.5, 125.0, 124.8, 123.3, 121.0, 113.6 (Ar-C), 
56.2 (CH2), 27.4 (CH2CH2CH2), 27.2 (CH2CH2CH2), 23.7 (CH3COO), 21.4 
(CH2CH2CH2). 31P NMR (CDCl3): δ 54.2, 14.6 Hz (m). MS (ESI, positive 
mode) m/z (%): 797.9 (100) [M – Br]+. 
3.4.3 General Procedure for the Tranfer Hydrogenation Reaction 
The transfer hydrogenation experiments were carried out using standard 
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Schlenk techniques. A mixture of an appropriate amount of 3.1–3.5 (1 
mol %), and the ketone (1 mmol) was dissolved in 2-propanol (20 mL). The 
solution was heated to 82 °C. The reaction commenced immediately upon 
addition of 0.1 M NaOBut (1 mL) . After ca. 24 h reflux, the mixture was 
passed through a small column of silica gel and eluted with Et2O. The crude 
product was collected for GC-Mass chromatography analysis. 
3.4.4 X-Ray Diffraction Studies 
Suitable crystals were mounted on quartz fibers and X-ray data were collected 
on a Bruker AXS APEX diffractometer equipped with a CCD detector, using 
graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The data were 
corrected for Lorentz and polarization effects with the SMART program suite 
and for absorption effects with SADABS. The crystal structures were solved 
by direct methods and refined by full-matrix least squares on F2 using the 
SHELXTL program package.216 In 3.1, the hydrogen atoms of the partially 
occupied free water were not located while the hydrogen atoms of the water 
were located from the difference Fourier map and refined with restraints in 
bond lengths and thermal parameters in 3.2. There are two phenyl rings 
disordered into two positions with the corresponding occupancy ratios of 
0.51/0.49 and 0.47/0.53 in 3.5b. All non-hydrogen atoms were refined 
anisotropically. Hydrogen atoms were calculated in ideal geometries and 
refined isotropically. Selected crystal data for complexes 3.1–3.5 are 
summarized in Table 4. 
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Table 3.4 Summary of crystallographic parameters and refinement results for  
complexes 3.1–3.5 








fw 853.69 870.71 1189.53 
cryst. Syst. Monoclinic Monoclinic Monoclinic 
space group P2(1)/n P2(1)/n P2(1)/n 
a (Å) 12.648(1) 13.2523(6) 16.771(7) 
b (Å) 11.625(1) 10.7742(5) 16.975(7) 
c (Å) 25.720(2) 26.924(1) 18.167(8) 
α (°) 90 90 90 
β (°) 95.695(2) 99.429(1) 108.42(1) 
γ (°) 90 90 90 
V (Å3) 3762.8(6) 3792.4(3) 4907(4) 
Z 4 4 4 
Dcalcd (g·cm–3) 1.507 1.525 1.610 
μ (mm–1) 1.656 1.645 1.786 
F(000) 1728 1764 2400 
no. of reflns collected 26079 26039 33942 
no. of unique reflns 8633 8679 11245 
Rint 0.0481 0.0685 0.1131 
no. of observed reflns 6342 6371 7363 
parameters 477 467 587 
T (K) 223(2) 223(2) 100(2) 
R1a (all data) 0.0662 0.0820 0.1259 
wR2b(all data) 0.1027 0.1179 0.2136 
GOFc 0.991 1.018 1.045 
Δρmax (e Å–3) 0.631 1.003 1.853 
Δρmin (e Å–3) -0.315 -0.542 -1.682 
    








fw 891.77 1116.48 876.73 
cryst. Syst. Orthorhombic Triclinic Triclinic 
space group Pbca P-1 P-1 
a (Å) 11.9272(5) 8.782(1) 10.318(1) 
b (Å) 19.5253(8) 14.294(2) 12/481(1) 
c (Å) 32.640(1) 19.356(3) 16.283(1) 
α (°) 90 107.130(3) 103.897(3) 
β (°) 90 98.111(3) 101.402(2) 
γ (°) 90 95.118(3) 106.085(3) 
V (Å3) 7601.2(5) 2276.5(6) 1875.6(4) 
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Z 8 2 2 
Dcalcd (g·cm–3) 1.558 1.629 1.552 
μ (mm–1) 1.643 1.730 1.663 
F(000) 3632 1124 890 
no. of reflns collected 52301 29231 13429 
no. of unique reflns 8732 10458 8548 
Rint 0.0714 0.0731 0.0374 
no. of observed reflns 6898 8665 6539 
parameters 470 533 546 
T (K) 100(2) 100(2) 100(2) 
R1a (all data) 0.0601 0.1039 0.0795 
wR2b(all data) 0.1073 0.1802 0.1964 
GOFc 1.043 1.171 1.049 
Δρmax (e Å–3) 1.391 1.750 1.381 
Δρmin (e Å–3) -0.530 -1.885 -0.854 
a R1 = Σ||Fo|-|Fc||/Σ|Fo|. b wR2 = {wΣ(|Fo|-|Fc|)2/Σw|Fo|2}}1/2. c GOF = 
{Σw(|Fo|-|Fc|)2/(n-p)}1/2, where n is the number of reflections and p is total number of
parameters refined 
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Chapter 4 One-Step Synthesis and Structures of 
Olefin-Tethered N,S-Heterocyclic Carbene Complexes 
of Ruthenium with Mixed-Ligands 
 
4.1 Introduction 
Unsupported metal-coordinated η2 olefin is a key element in various catalytic 
cycles.134,215,217-227 Many of these olefins only weakly interact with the metal 
and such fleeting nature could hinder them from being detected or 
isolated.228-233 Introduction of a supplementary functionality to promote 
coordination through proximity effect has proven to be effective.59,234-240 This 
is demonstrated by the use of carbene as an anchor to promote metal-olefin 
interaction as found in the emerging N,N-heterocylic carbene (NNHC) (Pd(II), 
Ru(II), Ir(I))80,241-242 and N,S-heterocylic carbene (NSHC) metal (Pd(II), Cu(I), 
Au(III), Rh(I), Ir(I)) complexes.56,59,63-64,243 As part of our continual effort in 
developing catalytically active Ru(II)-NSHC complexes, we herein report the 
synthesis and structures of a new series of olefin-tethered Ru(II)-NSHC 
complexes. Since ligand hemilability is a desirable feature of active 
catalysts,244-254 a combinative use of carbene and olefin with robust and fragile 
M-C bond respectively is expected to enable the metal to be more adaptable to 
coordinative changes. Accordingly, the complexes have been examined for 
their applicability in selective hydrosilylation of terminal alkynes. 
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4.2 Results and Disscussion 
4.2.1 Synthesis of Benzothiazolium Salts 
Benzothiazolium bromide salts [(C6H4)SCHNR]Br (R = propenyl (L4); 
2-propenyl (L5); 3-methyl butenyl (L6)) with different nitrogen substituents 
could be obtained as off-white or light yellow powder in good yields (>80%) 
by treatment of the freshly distilled benzothiazole and appropriate alkyl halide 
60 °C using a solvent-free method (Scheme 4.1).58 Their 1H NMR spectra 
invariably show downfield resonances for the SCHN protons in the range of 
12.05-12.28 ppm. These benzothiazolium salts are good precursors to 
ruthenium NSHC complexes. 
 
 
Scheme 4.1. Synthesis of benzothiazolium salts L4–L6 
 
4.2.2 Synthesis and Characterization of Complexes 4.1–4.4 
One-pot reactions between Ru(OAc)2(PPh3)2 and a series of olefin-bearing 
benzothiazolium bromides L4–L6 in dry THF yielded three chemically 
different benzothiazol-2-ylidene (BzTh) Ru(II)-NSHC complexes, viz. 
RuBr2(PPh3)2(N-AyBzTh) (Ay = propenyl) (4.1), 
RuBr(OAc)(PPh3)(N-MeAyBzTh) (MeAy = 2-methylpropenyl) (4.2), and 
RuBr(OAc)(PPh3)(N-MeBnBzTh)2 (MeBn = 3-methylbutenyl) (4.3). The 
reaction with L6 also gave a minor product RuCl(OAc)(PPh3)(N-MeBnBzTh)2 
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(4.4). (Scheme 4.2) These compounds are formed as a result of concomitant 
condensation and ligand exchanges, made possible by the benzothiazolium 
bromides serving as sources for carbene, olefin and halide ligands as well as 
proton for condensation. Formation of these complexes is ensured by the 
elimination of at least one acetate ligand (in form of HOAc) thus providing the 
vacant sites for carbene and olefin entry. Formation of 4.1 suggests that 
phosphine dissociation is not a necessary prerequisite. It is also the only dihalo 
and acetate-free complex, thus emphasising the halide-acetate exchange ability. 
Complex 4.2 is the expected stoichiometric product, giving all-different 
ligands on a Ru(II) core. Complex 4.3 highlights a potential access to 
di-carbene whose formation would deem olefin coordination unnecessary. Its 
pendant olefin also demonstrates the hemilability of these carbene-olefin 
hybrid ligands in this series of products. Complex 4.4 is related to 4.2 except 
with a different N-substituent and bromide replacement by chloride, the latter 
of which probably occurs during the recrystallization process when in contact 
with CH2Cl2. These complexes are readily soluble in CHCl3, CH2Cl2 and THF 
but less soluble in toluene. They are relatively stable as solids but slowly 
decompose in solution as indicated by a gradual color change from yellow to 
dark brown or green. 
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Scheme 4.2. Synthesis of Ru(II) benzothiazol-2-ylidene complexes 4.1–4.4 
 
4.2.3 NMR Studies of Complexes 4.1 to 4.4 
Chelation coordination of the hybrid ligands in 4.1 and 4.2 is inferred from 
spectroscopic measurements in solution. 1H and 13C NMR spectra of 4.1 show 
the γ-H (CH2-CH=CH2) and olefin carbon CH2-CH=CH2 resonances at δ 3.92, 
3.13 ppm (AMX pattern) and δ 67.8 ppm, respectively, which are significantly 
upfield shifted compared to its precursor L1 (δ 5.81 ppm for γ-H and δ 130.4 
ppm for olefin carbon). Such upfield shifts are consistent with significant 
π-back-bonding from the metal to the olefinic π*-orbital and with a 
concomitant weakening of the C=C bond order.255-256 Similar observations are 
apparent in 4.2 which shows γ-H resonances of δ 4.22/2.15 ppm and olefin 
carbon (CH2-CH=CH2) at δ 86.9 ppm, respectively. 
Complexes 4.3 and 4.4 are fluxional in solution, the nature of which is 
presently unclear. The 31P NMR spectrum of the former shows a set of 
resonances at δ 59.9, 57.9 and 57.4 ppm indicating the fluxional olefin 
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coordination and rotation. Although several isomers are apparent in solution 
(31P NMR), only one form (4.3) was isolated in its solid state. The 31P NMR 
spectrum of 4.4 shows two resonances at δ 53.6 and 39.6 ppm. The former is 
ascribed to the coordinated olefin whereas the latter refers to the 
uncoordinated olefin. 
4.2.4 Molecular Structures of Complexes 4.1–4.4 
X-ray single-crystal structure analysis was carried out on all products but the 
data of 4.3 are not of sufficient quality to justify detailed discussion. They 
invariably revealed a common octahedral structure of these Ru(II) NSHC 
carbene complexes with the anticipated η2 coordinated olefin for 4.1, 4.2 and 















Figure 4.1. Ortep diagrams of the structures of 4.1–4.4 with 50% probalility ellipsoids. 
All hydrogen atoms and solvent molecule are omitted for clarity. 
 
All crystal structures are in agreement with those deducted from solution 
spectroscopic data. In 4.1, the NSHC carbene, two bromides and η2 olefin 
occupy the four equatorial sites (mean deviation 0.0350 Å) whilst the two 
trans-phosphine ligands are at axial positions. As expected, the carbene 
(Ru(1)-C(1) 1.987(5) Å) is trans to bromide, thus avoiding a strong trans 
ligand such as phosphine. The olefin attachment is slightly asymmetrical, with 
the external Ru-C bond being longer (Ru(1)-C(10)) = 2.256(6) Å) than the 
internal one (Ru(1)-C(9) = 2.219(6) Å). (Table 4.1) This is in contrast with the 
olefin-functionalized complex RuL(CO)2(PPh3) (L = 
1-mesityl-3-(η2-but-3-en-1-yl)imidazol-2-ylidene) in which the internal 
Ru-Colefin bond is longer (2.2076(14) Å).80 The olefinic C-C (C9-C10 = 
1.334(7) Å) is significantly longer than an unperturbed C=C bond (1.299 Å), 
thus supporting Ru-olefin interaction.257  
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Table 4.1 Selected bond lengths (Å) and angles (°) for 4.1–4.2 and 4.4 
 4.1 4.2 4.4 
Ru(1)-C(1) 1.987(5) 1.960(4) 1.938(5) 
Ru(1)-P(1) 2.438(2) 2.287 (1) 2.303(1) 
Ru(1)-P(2) 2.438(2) - - 
Ru(1)-C(9) 2.219(6) 2.183(4) 2.215(5) 
Ru(1)-C(10) 2.256(6) 2.202(4) 2.235(6) 
Ru(1)-Br(1) 2.5427(7) 2.6214(6) - 
Ru(1)-Br(2) 2.6645(7) - - 
Ru(1)-O(1) - 2.153(3) 2.145(4) 
Ru(1)-O(2) - 2.214(3) 2.198(4) 
C(9)-C(10) 1.317(7) 1.398(6) 1.381(8) 
C(8)-C(9) 1.511(8) 1.528(6) 1.537(7) 
    
P(1)-Ru(1)-P(2) 173.36(5) - - 
C(9)-Ru(1)-C(10) 34.7(2) 37.2(2) 36.1(2) 
 
Complex 4.2 has retained one of the acetates, which is chelating and trans 
to the olefin and phosphine. Removal of a PPh3 ligand has eased the steric 
congestion on the coordination sphere, which probably explains the slight 
shortening of both metal-carbene (1.960(4) Å) and metal-olefin (Ru(1)-C(9), 
2.183(4) Å & Ru(1)-C(10), 2.202(4) Å) contacts as compared to 4.1. 
Complex 4.3 is the first example of a Ru(II) complex with two 
N,S-heterocyclic carbene ligands. This is in contrast to our earlier futile 
attempt to isolate such complexes.202 With phosphine, chelating acetate and 
bromide ligands, there is no further room for olefin coordination. Its isolation 
suggests that these carbene-olefin hybrids are stable in their unidentate mode, 
i.e. even when the olefin is in a pendant state. This is an important 
consideration in the design of coordinatively flexible catalysts supported by 
this type of hybrid ligands. The crystallographic data revealed that, as 
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expected, the carbenes avoid trans position to each other and also avoiding the 
trans phosphine. The poor quality of the data however precludes further 
discussion of the bond data.  
Similar to 4.2, complex 4.4 contains five different donor ligands, including 
a coordinated olefin, on the Ru(II) sphere. It also has the shortest Ru-Ccarbene 
bond (1.938(5) Å) in this series, which is consistent with the least congested 
coordination sphere and also compensating for a longer Ru-Colefin contact 
(Ru(1)-C(9), 2.215(5) Å and Ru(1)-C(10), 2.235(6) Å) (relative to 4.2).  
4.2.5 Hydrosilylation of Terminal Alkynes 
Complexes 4.1–4.3 were examined for their catalytic activities in transfer 
hydrosilylation of alkynes.114-115,258 (Table 4.2) The reaction between 
phenylacetylene and triethylsilane catalysed by 1 mol% of catalyst at 100 °C 
(run 1 to 3) gives predominantly the Z-isomer of alkenylsilane.(Table 4.2) 
Catalysts 4.2 and 4.3 (~60% yields) are generally more reactive than 4.1 (40% 
yield). This could be rationalised as dissociation of acetate (as in 4.2 & 4.3) 
could pave a direct and facile entry to an unsaturated metal, especially under 
thermal conditions. Over-saturation of the metal with two PPh3 (as in 4.1) is 
also undesirable. This is in agreement with the findings by Oro and 
co-workers who reported that RuH(OAc)(CO)(PPh3)2 with two phosphines 
gave lower yield and selectivity.259 Since 4.2 also gives a slightly better 
selectivity of 1:20 for β(E):β(Z), its effect on different silanes and alkynes has 
been further examined (run 4 to 5). With the more bulky 
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bis(trimethylsiloxy)methylsilane, Z-isomer is still the favored product, albeit 
in a lower yield of ~33%. Use of a bulkier alkyne (R = Me3Si) surprisingly 
gives dehydrogenative silylation as main product (76%) instead of 
hydrosilylation. This may be attributed to weaker metal coordination of alkyn 
under the influence of a bulky alkyne.116-117,260 
Ru-NHC-catalysed hydrosilylation is generally rare in the literature. Among 
those the few examples are catalyzed by Grubbs’ second generation 
catalysts.114-115 For example, RuCl2(IMes)(PCy3)(=CHPh)114 favors the 
formation of the Z isomer (β(Z):β(E):α = 14.5:0:1) with ~50% yield in a 
reaction between phenylacetylene and triethylsilane with 1 mol% of catalyst at 
65 °C for 16 h. This is comparable to our system. However, other non-carbene 
systems such as RuHCl(CO)(PiPr3)2, RuH(OAc)(CO)(PiPr3)2, 
[RuCl2(p-cymene)]2 and RuCl(CO)(SiMe2Ph)(PiPr3)2 have been reported to 
give better yield (> 80%) with selectivity β(Z):β(E) > 95/5 in the reaction 
between phenylacetylene and triethylsilane.259,261-263 These systems could be 
carried out at lower temperature and completed within a short duration. For 
example, high selectivity (β(Z):β(E) = 97/2) and yield (97%) of the Z isomer 
could be obtained with 1 mol% catalyst RuH(OAc)(CO)(PiPr3)2 loading in 














α (%) β(E) (%) β(Z) (%) A 
1a 4.1 49 1 3 40 4 
2 a 4.2 80 2 3 63 11 
3 a 4.3 83 1 4 64 11 
4b 4.2 41 1 2 33 5 
5c 4.2 87 3 2 1 76 
Reaction condition:100 °C, 24 h; a R’= Ph, R = Et; b R’ = Ph, R3 = 




Isolation of these complexes under self-assembly conditions suggested that 
Ru(OAc)2(PPh3)2 is a suitable precursor for this type of mixed-ligand 
carbene-olefin complexes and that a variety of ligand combinations can be 
tolerated by Ru(II). The multitude of alternatives (viz. mono- or di-carbene, 
mono- or bis-phosphine, carbene or phosphine, coordinated or pendant olefin, 
acetate or halide, acetate or phosphine, etc) provides the metal ample choice of 
a suitable ligand environment that is most conducive of its stabilisation. It also 
provides an entry to asymmetric Ru(II) with all-different ligands through a 





4.4 Experimental Section 
4.4.1 General Procedures and Materials 
All manipulations were carried out under a nitrogen atmosphere using 
standard Schlenk techniques. Ru(OAc)2(PPh3)2 were prepared according to 
the literature method.157 Other commercially available reagents were 
purchased from Sigma-Aldrich. All solvents were freshly distilled from 
standard drying agents. 1H, 13C and 31P NMR spectra were recorded on a 
Bruker AMX 500 spectrometer. The chemical shifts (δ) are referenced to 
TMS for 1H and 13C{1H} and H3PO4 (85%) for 31P{1H}. Elemental analyses 
were performed on a Perkin-Elmer PE 2400 elemental analyzer. The yields 
of hydrogenation products were determined by using Hewlett Packard 
Series 6890 GC (Santa Clara, CA, USA) coupled to a Hewlett Packard 
5973 MS detector. 
4.4.2 General procedures for the Preparation of Ligands (L4–L6) 
A mixture of benzothiazole (2.71 g, 20.0 mmol) and allyl bromide (22.0 
mmol) was stirred at 60 °C overnight to yield a large amount of yellow 
crude product. It was washed with Et2O and small amount of CH2Cl2 to 
afford light yellow powder which was collected and dried in vacuum. 
N-propenylbenzothiazolium bromide (L4) 
Yield: 4.87 g (19.0 mmol, 95%). 1H NMR (500.1 MHz, CD2Cl2): δ 12.28 (s, 
1H, NCHS), 8.27 (d, 1H, 3JHH = 8.0 Hz, Ar-H), 8.05 (d, 1H, 3JHH = 8.4 Hz, 
Ar-H), 7.87 (m, 1H, Ar-H), 7.81 (m, 1H, Ar-H), 6.17 (m, 1H, CH=CH2), 
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5.81 (d, 2H, 3JHH = 6.0 Hz, CH2), 5.57 (d, 1H, 3JHH = 17.1 Hz, 
CH=CHHtrans), 5.53 (d, 1H, 3JHH = 10.4 Hz, CH=CHHcis). 13C NMR (125.8 
MHz, CD2Cl2): δ 166.0 (NCS), 140.6 (Ar-C), 130.4 (CH=CH2) 129.4, 
129.1, 125.1, 123.0 (Ar-C), 117.2 (CH=CH2) 55.5 (CH2).  
N-(2-methyl)propenylbenzothiazolium bromide (L5) 
Yield: 4.50 g (16.6 mmol, 83%). 1H NMR (500.1 MHz, CD2Cl2): δ 12.07 (s, 
1H, NCHS), 8.41 (d, 1H, 3JHH = 8.2 Hz, Ar-H), 8.08 (d, 1H, 3JHH = 8.2 Hz, 
Ar-H), 7.82 (m, 1H, Ar-H), 7.78 (m, 1H, Ar-H), 5.80 (s, 2H, CH2), 5.13 (s, 
1H, CH=CH2), 4.95 (s, 1H, CH2), 1.78 (s, 3H, CH3). 13C NMR (125.8 MHz, 
CD2Cl2): δ 165.8 (NCS), 140.5, 137.2 (Ar-C), 131.4 (CH=CH2), 130.0, 
129.0, 129.1, 125.1, 117.1 (Ar-C), 116.4 (CH=CH2), 58.5 (CH2), 19.6 
(CH3). Anal. Calc for C11H12BrNS: C, 48.89; H, 4.48; N, 5.18. Found: C, 
48.68; H, 4.11; N, 5.05. 
N-(3-methyl)butenylbenzothiazolium bromide (L6) 
Yield: 4.55 g (16.0 mmol, 80%). 1H NMR (500.1 MHz, CD2Cl2): δ 12.05 (s, 
1H, NCHS), 8.30 (d, 1H, 3JHH = 8.2 Hz, Ar-H), 7.99 (d, 1H, 3JHH = 8.8 Hz, 
Ar-H), 7.85 (m, 1H, Ar-H), 7.79 (m, 1H, Ar-H), 5.64 (d, 2H, 3JHH = 7.6 Hz, 
CH2), 5.50 (m, 1H, CH=C), 1.97 (s, 3H, CH3), 1.83 (s, 3H, CH3). 13C NMR 
(125.8 MHz, CD2Cl2): δ 165.2 (NCS), 143.6, 140.4 (Ar-C), 131.7 (CH=C), 
129.9, 129.0, 124.8, 116.8 (Ar-C), 114.6 (CH=C), 51.7 (CH2), 25.5 (CH3), 
18.7(CH3). Anal. Calc for C12H14BrNS: C, 50.71; H, 4.96; N, 4.93. Found: 
C, 50.70; H, 4.75; N, 4.65. 
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4.4.3 General Procedures for the Preparation of Complexes 4.1–4.4 
General procedures for the preparation of complexes (4.1–4.2) 
A mixture of Ru(OAc)2(PPh3)2 (0.25 mmol, 0.186 g), NaOAc (0.042 g, 0.5 
mmol) and L4 or L5 (0.50 mmol) was stirred under vacuum at 50 °C for 1 h. 
THF (15 mL) was then added and the suspension refluxed overnight. After 
cooling, the solvent was removed under vacuum, leaving a yellow residue, 
which was washed with hexane and re-dissolved in CH2Cl2 (15 mL). The 
filtrate was diffused with hexane to yield yellow crystals in 1-2 weeks. 
RuBr2(PPh3)2(N-AyBzTh) (4.1) 
Yield: 0.17 g (0.18 mmol, 72%). 1H NMR (500.1 MHz, CD2Cl2): δ 
7.80-7.77 (m, 8H, Ar-H), 7.34 (m, 6H, Ar-H), 7.17-7.02 (m, 21H, Ar-H), 
6.81 (d, 1H, Ar-H), 4.90 (m, 1H, CH=CH2), 4.06 (d, 1H, CH=CH2), 3.92 (q, 
1H, 2JHH = 12.0 Hz, 3JHH = 6.3 Hz, CH2), 3.63 (m, 1H, CH=CH2), 3.13 (q, 
1H, 2JHH = 12.0 Hz, 3JHH = 5.6 Hz, CH2). 13C NMR (125.8 MHz, CD2Cl2): δ 
141.4, 136.8, 134.6, 134.2, 133.8, 133.6, 129.2, 129.0, 128.6, 128.2, 127.2, 
125.0, 122.8, 120.9, 111.3 (Ar-C), 67.8 (CH=CH2), 66.3 (CH2), 51.9 
(CH=CH2). 31P NMR (202.4 MHz, CD2Cl2): 21.6, 18.6 (q, 2JPP = 325 Hz). 
Anal. Calc for C46H39Br2NP2RuS·(CH2Cl2)0.8: C, 54.64; H, 3.98; N, 1.36. 
Found: C, 54.75; H, 3.68; N, 1.30. 
RuBr(MeCOO)(PPh3)(N-MeAyBzTh) (4.2) 
Yield: 0.14 g (0.20 mmol, 80%). 1H NMR (500.1 MHz, CD2Cl2): δ 7.37 (d, 
1H, Ar-H), 7.31-7.26 (m, 10H, Ar-H), 7.21-7.11 (m, 7H, Ar-H), 7.05 (d, 1H, 
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Ar-H), 4.22 (d, 1H, 2JHH = 12.0 Hz, CH2), 4.01 (s, 1H, C=CHHtrans), 3.05 (d, 
1H, JHH = 11.4 Hz, C=CHHcis), 2.15 (d, 1H, 2JHH = 12.0 Hz, CH2), 1.89 (s, 
3H, CH3COO), 1.64 (s, 3H, CH3). 13C NMR (125.8 MHz, CD2Cl2): δ 231.3 
(2JCP = 15 Hz, NCS), 188.0 (CH3COO), 142.8, 138.3, 134.2, 134.1, 132.9, 
132.5, 130.2, 129.2, 128.4, 128.1, 128.0, 126.8, 125.5, 124.1, 122.3, 112.6 
(Ar-C), 86.9 (C=CH2), 59.7 (C=CH2), 58.9 (CH2), 25.3 (CH3COO), 25.1 
(CH3). 31P NMR (202.4 MHz, CD2Cl2): 55.7 (s). Anal. Calc for 
C31H29BrNO2PRuS: C, 53.84; H, 4.23; N, 2.02. Found: C, 53.53; H, 4.11; N, 
1.67. 
Procedures for the preparation of complexes 4.3 and 4.4 
A mixture of Ru(OAc)2(PPh3)2 (0.25 mmol, 0.186 g), NaOAc (0.042 g, 0.5 
mmol) and ligands L6 (0.50 mmol) was stirred under vacuum at 50 °C for 1 
h. THF (15 mL) was then added and the suspension refluxed overnight. 
After cooling, the solvent was removed under vacuum, leaving a yellow 
residue, which was washed with hexane and re-dissolved in toluene (15 
mL). The filtrate was diffused with hexane to yield mixed yellow and 
orange crystalline solid in 1-2 weeks. The solid was re-dissolved in hot 
toluene (10 mL) and filtered. The filtrate was diffused with hexane to yield 
crystals (4.3) in a week. The residual powder was recrystallized from 
CH2Cl2 (5 mL) and hexane (10 mL) to yield 4.4. 
RuBr(MeCOO)(PPh3)(N-MeBnBzTh)2 (4.3) 
Yield: 0.10 g (0.11 mmol, 45%). 1H NMR (500.1 MHz, CD2Cl2): δ 
97 
7.34-7.18 (m, Ar-H), 7.15-7.11 (m, Ar-H), 6.69 (m, CH2), 5.85 (m, CH2), 
5.52 (m, CH2), 5.32 (m, CH), 5.31 (m, CH2), 5.17 (m, CH2), 4.92 (m, CH), 
4.83 (m, CH2), 3,43 (m, CH2), 1.98 (s, CH3), 1.86 (s, CH3), 1.75-1.60 (CH3 
& CH3COO), 1.16 (s, CH3). 31P NMR (202.4 MHz, CD2Cl2): 59.9, 57.9 and 
57.4 (s). Anal. Calc for C44H44BrN2O2PRuS2: C, 58.14; H, 4.88; N, 3.08. 
Found: C, 57.90; H, 4.10; N, 2.96. 
RuCl(MeCOO)(PPh3)(N-MeBnBzTh) (4.4) 
Yield: 0.007 g (0.01 mmol, 4%). 1H NMR (500.1 MHz, CD2Cl2): δ 
7.24-6.80 (m, 19H, Ar-H), 6.57 (s, CH2CH=C(CH3)2), 3.98 (m, 
CH2CH=C(CH3)2) 3.53 (d, CH2CH=C(CH3)2), 3.10 (d, CH2CH=C(CH3)2), 
2.66 (m, CH2CH=C(CH3)2), 1.98 (s, CH3), 1.23, 1.21 (CH3, CH3COO), 0.71, 
0.69 (s, CH3, CH3COO), 0.57 (CH3). 31P NMR (202.4 MHz, CD2Cl2): 53.6, 
39.6 (s). Anal. Calc for C32H31ClNO2PRuS: C, 58.13; H, 4.73; N, 2.12. 
Found: C, 58.48; H, 5.04; N, 2.49. 
4.4.4 General Procedure for the Tranfer Hydrosilylation Reaction 
The transfer hydrosilylation experiments were carried out using standard 
Schlenk techniques. A mixture of appropriate amount of ruthenium 
complexes 4–6 (1 mol %), acetylene (1.2 mmol) and silane (1 mmol) was 
dissolved in toluene (15 mL). The solution was heated to 100 °C for about 
24 h. The reaction mixture was then directly passed through a pad of silica 
gel with CH2Cl2. The crude product was collected for GC-Mass 
chromatography analysis. 
4.4.5 X-Ray Diffraction Studies 
Suitable crystals were mounted on quartz fibers and X-ray data were collected 
98 
on a Bruker AXS APEX diffractometer equipped with a CCD detector, using 
graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The data were 
corrected for Lorentz and polarization effects with the SMART program suite 
and for absorption effects with SADABS. The crystal structures were solved 
by direct methods and refined by full-matrix least squares on F2 using the 
SHELXTL program package.216 In complex 4.2, half of a toluene disordered 
into two positions which was replaced by half a disordered dichloromethane. 
All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were 
calculated in ideal geometries and refined isotropically. Selected crystal data 
for complexes 4.1–4.2 and 4.4 are summarized in Table 4.3. 
 
Table 4.3 Summary of crystallographic parameters and refinement results for complexes 
4.1–4.2 and 4.4 








fw 1045.60 780.09 753.26 
cryst. Syst. Triclinic Monoclinic Triclinic 
space group P-1 P2(1)/n P-1 
a (Å) 11.322(2) 10.207(1) 10.208(1) 
b (Å) 12.461(1) 14.900(2) 12.203(2) 
c (Å) 17.103(2) 20.374(3) 14.881(2) 
α (°) 100.799(2) 90 87.596(3) 
β (°) 95.825(2) 98.004(3) 71.425(3) 
γ (°) 114.979(2) 90 80.448(3) 
V (Å3) 2103.9(4) 3068.5(6) 1732.6(4) 
Z 2 4 2 
Dcalcd (g·cm–3) 1.651 1.689 1.444 
μ (mm–1) 2.560 2.056 0.672 
F(000) 1048 1576 776 
no. of reflns collected 27756 21534 22698 
no. of unique reflns 9636 7041 7948 
Rint 0.0800 0.0419 0.0824 
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no. of observed reflns 6892 5825  
parameters 515 417 419 
T (K) 90(2) 90(2) 100(2) 
R1a (all data) 0.0893 0.0575 0.0995 
wR2b(all data) 0.1348 0.1336 0.1694 
GOFc 1.045 1.068 1.143 
Δρmax (e Å–3) 1.340 1.039 1.668 
Δρmin (e Å–3) -1.029 -1.335 -1.311 
 
a R1 = Σ||Fo|-|Fc||/Σ|Fo|. b wR2 = {wΣ(|Fo|-|Fc|)2/Σw|Fo|2}}1/2. c GOF = 
{Σw(|Fo|-|Fc|)2/(n-p)}1/2, where n is the number of reflections and p is total number of 
parameters refined. 
100 
Chapter 5 Reactivity of Ru(II)-NSHC Complexes 
RuBr(RCOO)(NSHC)(PPh3)2 (R = Me, Et) 
 
5.1 Intramolecular sp2 and sp3 C-H Bond Activation of 
Ruthenium N-heterocyclic Carbene Complexes  
 
5.1.1 Introduction 
Recent studies revealed that the NHC ligands are not as inert as one would 
anticipate. They are susceptible to C-C/H/N activation264-271 and reductive 
elimination272-273 at N-bound substituents, which is relevant to the study of 
catalytic activation or deactivation pathways.86,147,179,232,272-275 Examples of 
these are found among the Ru-NHC complexes which could undergo these 
intramolecular processes and generate the stable cyclometalated 
species.80,86-88,270-271,276-279 Whittlesey and co-workers have reported the first 
example of C-C bond activation from Ru(H)2(PPh3)(CO)(IMes)2.271 The C-H 
activation of the backbone of [(p-cymene)Ru(NHC)X2] species have also been 
explored by Dixneuf et al. and Wang et al.277,279 However, the driving force of 
these activation is still not clear. Thus, more details about reaction conditions, 
structures and reactivities for cyclometalated Ru-NHC complexes are required. 
As part of our interest in Ru(II)-NSHC complexes, we herein discuss in this 
chapter the intramolecular sp2 and sp3 C-H bond activation at the 
RuBr(RCOO)(NSHC)(PPh3)2 (R = Me, Et) complexes. Within our knowledge, 
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this is the first time that the activation of unreactive bonds occurs at 
Ru(II)-NSHC complexes.  
 
5.1.2 Results and Discussion 
5.1.2.1 Synthesis and Characterization of Complexes 5.1–5.2 
Reactions of complexes 2.1 and 2.2 with 2.2 equiv. of IMes (IMes = 
N,N’-2,4,6-bis(trimethylphenyl)imidazol-2-ylidene) yielded the substitution 
product RuBr(RCOO)(PPh3)(3-BzBzTh)(IMes-H) (3-BzBzTh = 
3-benzylbenzothiazol-2-ylidene; R = Me (5.1a); Et (5.1b)) with C-H 
activation; more surprisingly, it also generated 
RuBr(RCOO)(PPh3)2(3-(Bz-H)BzTh) (R = Me (5.2a); Et (5.2b)) as minor 
product (Scheme 5.1). It suggested that the IMes should act as not only a 
nucleophilic reagent but also a Lewis base. This is similar as reported by 
Whittlesey87-88. For example, that the formation of intramolecular C-H 
complex Ru(IMes-H)(dppp)(CO)H required heat and an excess carbene, 
which resulted in a base induced elimination of HF in precursor 
Ru(PPh3)(dppp)(CO)HF. Further experiments were carried out to attempt to 
obtain the di-IMes substituted products but without success, even when 3 fold 
of IMes was introduced. The access of the second IMes ligand is probably 
hindered by the steric bulkiness of the first one. In addition, as it is difficult to 
isolate complex 5.2 in its pure form, an alternative route to 5.2 was introduced 
which involves the reaction of complexes 2.1 and 2.2 with 1.2 equiv. sodium 
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tert-butoxide in toluene. Sodium tert-butoxide was found to be a satisfactory 
base for the formation of complexes 5.2a and 5.2b. While for the other bases 
such as NaOMe and KOtBu, the reaction gave the mixture of complex 5.2 and 
some uncharacterizable products. Complexes 5.1–5.2 are stable in the solid 
state but they decompose in solution in the air. They are readily soluble in 
common organic solvent such as toluene, THF and CH2Cl2. The elemental 
analyses were consistent with their formulae. 
 
 
Scheme 5.1 Synthetic route of complexes 5.1 and 5.2 
 
5.1.2.2 Molecular Structures of Complex 5.1b and 5.2a 
The molecular structures of 5.1b and 5.2a are shown in Figure 5.1. Their 
selected bond lengths and angles are given in Table 5.1. Complex 5.1b 
represents the first ruthenium complex with mixed NNHC and NSHC ligands. 
It displays a distorted-octahedral geometry with the IMes trans to phosphine 
as well as the NSHC and methylene trans to two oxygen. The IMes carbene 
ligand adopts a chelating coordination mode through sp3 C-H activation of one 
ortho methyl of the mesityl group. This C-H activation for metal carbene 
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complexes was firstly observed by Nolan et al. for 
rhodium-imidazole-2-ylidene complex280 and extended to Ru,271,276,87,279,281 
Ir,282-283 Ni, Pd and Pt complexes.284-286 For sp3 C-H activation in ruthenium 
case, most of the work was reported by Whittlesey on ruthenium hydride or 
dihydride species. Due to the C-H activation, a six-membered metallacycle is 
formed with the generation of a new Ru-C27 bond. This metallacycle adopts 
an envelope conformation with Ru1 pointing away by 1.319 Å from the 
C27C22C21N2C18 plane. The C(18)-Ru(1)-P(1) alignments is heavily 
distorted from linearity with 168.6(1)°, reflecting both the steric strain within 
the six-membered metallacycle and the steric repulsion between the mesityl 
ring and the N,S-heterocyclic ring. Meanwhile, to minimize the steric 
congestion around the ruthenium center, the Mes ligands (ring 
C21C22C23C24C25C26) are staggered with the imidazole rings 
(C18N2C19C20N3) displaying a dihedral angle of 43.5°. The weak 
trans-effect ligand acetate makes Ru(1)-C(27) length (2.131(3) Å) a bit shorter 
than the reported Ru(II)-(IMes-H) complexes RuH(IMes-H)(PPh3)2 (2.162(2) 
Å) and RuH(IMes-H)(PPh3)2(CO) (2.235(2) Å). NNHC and NSHC carbene 
ligands are in cis position with differentiable Ru-Ccarbene bond length. The 
Ru-CNSHC (1.925(4) Å) is shorter than Ru-CNNHC bond (2.071 (3) Å). This is 
also due to the trans ligand to each carbene. In addition, this Ru-CNSHC bond is 






Figure 5.1. Ortep diagrams of complexes 5.1b and 5.2a with 50% probability ellipsoids. 
All hydrogen atoms and solvent molecules are omitted for clarity 
 
Complex 5.2a also represents the first Ru-NSHC example with C-H bond 
activation on nitrogen substituent. The X-ray analysis confirms the trans 
arrangement of two phosphine ligands. It is static in solution, showing only a 
single δP resonance (36.0 ppm) suggesting phosphine equivalence. The 
octahedral coordinate sphere of ruthenium center is completed by acetate 
ligand trans to NSHC carbene ligand and aryl carbon atom of benzyl group. 
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The P-Ru-P alignments are slightly distorted from linearity (P-Ru-P: 
176.59(64)°). (Figure 5.1) A six-membered ruthenacycle is formed as a result 
of intramolecular sp2 C-H activation. It is in coplanar conformation. The 
formation of ruthenacycle is also indicated by the upfield H shift of methylene 
(δH resonance, 3.93 ppm) compared with 2.1 (δH resonance, 5.58 ppm). The 
benzothiazole moiety shares the same plane with both the ruthenacycle and 
benzyl ring. The chelate bite angle C(1)-Ru(1)-C(14) of 89.1(2)° is similar to 
the previously reported cyclometalated complex (87.9(3)°).278 The Ru-Ccarbene 
bond distance of 1.936(4) Å, which is particularly similar to that found in 
complex 5.1b, lies in the range of reported Ru(II)-NSHC complexes.202 The 
Ru-C bond distance for the cyclometalated benzyl ring is 2.203(4) Å, which is 
longer than the reported benzyl cyclometalated complex 2.014(7) Å. This may 
be due to the none trans ligand to the cyclometalated carbon in the reported 
five-coordinated ruthenium complex. The sp2 C-H activation of Ru-NHC 
complexes have been reported by Dixneuf et al. They stated a hypothesis that 
five-membered ruthenacycle is more favored than six-membered ruthenacycle 
for (p-cymene)Ru(II) centered complexes.287 This assumption was further 
proved by Zhang’s work.279 However, sp2 C-H activation 
non-(p-cymene)Ru(II) centered complexes is rare and only one such example 
Ru(Cl)(PPh3)2(BzIm) (BzIm = 1,3-dibenzylimidazolin-2-ylidene) in which the 
ruthenium center adopted trigonal biyramid configuration, was reported so 
far.278 In addition, recent studies disclosed that the steric repulsion may be the 
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dominant way to cause C-H activation.147,276,279 However, the formation of 
complex 5.2a here is properly due to the presence of strong base. 
 
Table 5.1 Selected bond lengths (Å) and angles (°) for 5.1b and 5.2a 
 5.1b 5.2a 
Ru(1)-C(1) 1.925(4) 1.936(4) 
Ru(1)-C(18) 2.071(3) - 
Ru(1)-C(27) 2.131(3) - 
Ru(1)-C(14) - 2.203(4) 
Ru(1)-P(1) 2.400(1) 2.351(1) 
Ru(1)-P(2) - 2.368(1) 
Ru(1)-O(1) 2.333(2) 2.203(3) 
Ru(1)-O(2) 2.247(2) 2.354(3) 
   
C(18)-Ru(1)-P(1) 168.6(1) - 
P(1)-Ru(1)-P(2) - 176.59(4) 
C(1)-Ru(1)-C(14) - 89.1(2) 
dihedral angles 43.5a  
   
a dihedral angle between C18N2C19C20N3 and C21C22C23C24C25C26  
 
5.1.3 Summary 
Both sp3 C-H activation for IMes and sp2 C-H activation for BzBzTh have 
been shown to occur with the use of Ru-NSHC complexes 
RuBr(RCOO)(PPh3)2(NSHC) as starting material. Complex 5.2a generated 
herein represent the first cyclometalated Ru(II)-NSHC complex. This study 
may be important to understand catalytic pathways for certain organic 
reactions. Our efforts are directed toward extending the ligand scope as well as 
understanding their formation mechanism. 
 
5.1.4 Experimental Section 
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5.1.4.1 General Procedures and Materials 
All manipulations were carried out under a dry nitrogen atmosphere using 
standard Schlenk techniques. Complexes 2.1 and 2.2 were prepared according 
to the method described in chapter 2. Other commercially available chemicals 
were purchased from Sigma-Aldrich. All solvents were freshly distilled from 
standard drying agents. 1H (500.1 MHz), 31P (202.4 MHz) and 13C (125.8 
MHz) NMR spectra were recorded in ppm on a Bruker AMX 500 spectrometer. 
The chemical shifts (δ) are referenced to TMS for 1H and 13C{1H} and H3PO4 
(85%) for 31P{1H}. Elemental analyses were performed on a Perkin-Elmer PE 
2400 elemental analyzer. 
5.1.4.2 Synthesis of Complexes 5.1 and 5.2 
RuBr(MeCOO)(PPh3)(3-BzBzTh)(IMes-H) (5.1a). A 50 mL flask was 
charged with 0.0784 g of IMes·HCl (0.2 mmol), 0.0246 g of KOtBu (0.22 
mmol) and 20 mL of THF. The suspension was stirred at r.t. for 2 h, after 
which the solvent was removed under vacuum. The residue was extracted with 
20 mL toluene and filtered to another flask with 0.0891 g (0.1 mmol) of 
complex 1a. The clear orange solution was heated to 90 °C for 3 h and then 
stirred at r.t. for 12 h. After the solvent was removed, the red-brown color 
residue was washed with hexane (2×10 mL) and redissolved in toluene (10 
mL) with filtration. The red color crystals were obtained by diffusion of 
hexane to the former filtration. Yield: 0.036 g (38%). 1H NMR (CD2Cl2): δ 
7.53-7.45 (m, 9H, Ar-H), 7.29-7.24 (6H, Ar-H), 7.21-7.15 (m, 12H, Ar-H), 
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6.76 (b, 3H, Ar-H), 6.58 (b, 2H, Ar-H & CH2), 5.59 (m, 1H, CH2), 2.42 (b, 5H, 
CH2&CH3), 2.18 (b, 12H, CH2&CH3), 1.59 (s, 3H, CH3COO), 0.32 (m, 2H, 
CH2). 31P NMR (CD2Cl2): 62.3 (s). Anal. Calc for C55H52N3O2PRuS: C, 69.45; 
H, 5.51; N, 4.42. Found: C, 68.56; H, 5.53; N, 3.95. 
RuBr(EtCOO)(PPh3)(3-BzBzTh)(IMes-H) (5.1b). Prepared similar as 
complex 2a. 31P NMR (CD2Cl2): 61.0 (s). Anal. Calc for C56H54N3O2PRuS: C, 
69.69; H, 5.64; N, 4.35. Found: C, 68.70; H, 5.33; N, 4.06. 
RuBr(MeCOO)(PPh3)2(3-(Bz-H)BzTh) (5.2a). A 50 mL flask was charged 
with 0.0115 g of NaOtBu (0.12 mmol), 0.0891 g (0.1 mmol) of complex 1a 
and 20 mL of toluene. The mixture was heat to 90 °C for 12 h, after which the 
solvent was removed under vacuum. The residue was washed with hexane 
(2×10 mL) and redissolved in toluene (10 mL) with filtration. The yellow 
color crystals were obtained by diffusion of hexane to the filtration. Yield: 
0.046 g (51%). 1H NMR (CD2Cl2): δ 7.52 (m, 1H, Ar-H), 7.25-7.02 (34H, 
Ar-H), 6.63 (d. 1H, Ar-Hortho,S), 6.50 (t, 1H, Ar-H), 6.31 (t, 1H, Ar-H), 6.18 (d, 
1H, Ar-H), 3.93 (s, 2H, CH2), 1.33 (s, 3H, CH3COO). 13C NMR (CD2Cl2): δ 
231.5 (NCS), 180.6 (CH3COO), 158.3, 145.0, 137.9, 134.7, 134.2, 134.0, 
133.9, 129.0, 128.7, 128.1, 127.2, 127.1, 125.2, 124.5, 123.1, 122.0, 120.4, 
118.7, 109.9 (Ar-C), 56.2 (CH2), 23.3 (CH3COO). 31P NMR (CD2Cl2): 36.0 (s). 
Anal. Calc for C52H43NO2P2RuS: C, 68.71; H, 4.77; N, 1.54. Found: C, 67.90; 
H, 5.25; N, 1.53. 
RuBr(EtCOO)(PPh3)2(3-(Bz-H)BzTh) (5.2b). 1H NMR (CD2Cl2): δ 7.51 (m, 
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1H, Ar-H), 7.22-7.04 (34H, Ar-H), 6.64 (d. 1H, Ar-Hortho,S), 6.49 (t, 1H, Ar-H), 
6.31 (t, 1H, Ar-H), 6.18 (d, 1H, Ar-H), 3.92 (s, 2H, CH2), 1.62 (s, 2H, 
CH3CH2COO), 0.85 (s, 3H, CH3CH2COO). 31P NMR (CD2Cl2): 35.8 (s). 
C53H45NO2P2RuS: C, 68.97; H, 4.91; N, 1.52. Found: C, 68.48; H, 4.92; N, 
1.39. 
5.1.4.3 X-Ray Diffraction Studies 
Suitable crystals were mounted on quartz fibers and X-ray data were 
collected on a Bruker AXS APEX diffractometer equipped with a CCD 
detector, using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). 
The data were corrected for Lorentz and polarization effects with the 
SMART program suite and for absorption effects with SADABS. The 
crystal structures were solved by direct methods and refined by full-matrix 
least squares on F2 using the SHELXTL program package. In complex 5.1b, 
the asymmetric unit contains two molecules. One of the CH3CH2 of the 
carboxyl groups were disordered into to positions with occupancy ratio of 
77/23. In complex 5.2a, the toluene solvents was diordered into two 
positions with occupancy ration of 49/51. All non-hydrogen atoms were 
refined anisotropically. Hydrogen atoms were calculated in ideal 
geometries and refined isotropically. Selected crystal data for complexes 






Table 5.2 Summary of crystallographic parameters and refinement results for 
complexes 5.1b and 5.2a 
 5.1b 5.2a 
formula C56H54N3O2PRuS C59H51NO2P2RuS 
fw 965.12 1001.08 
cryst. Syst. Triclinic Monoclinic 
space group P-1 P2(1)/c 
a (Å) 13.7759(4) 11.838(1) 
b (Å) 13.0995(6) 17.830(2) 
c (Å) 20.0286(6) 22.598(2) 
α (°) 72.484(1) 90 
β (°) 70.520(1) 90.984(3) 
γ (°) 86.511(1) 90 
V (Å3) 4733.2(2) 4769.0(8) 
Z 4 4 
Dcalcd (g·cm–3) 1.354 1.394 
μ (mm–1) 0.455 0.485 
F(000) 2008 2072 
no. of reflns collected 62198 33476 
no. of unique reflns 21691 10926 
Rint 0.0674 0.0676 
no. of observed reflns 15682 8690 
parameters 1165 596 
T (K) 223(2) 100(2) 
R1a (all data) 0.0877 0.0930 
wR2b(all data) 0.1403 0.1475 
GOFc 1.033 1.165 
Δρmax (e Å–3) 0.911 1.076 
Δρmin (e Å–3) -0.564 -1.654 
 
a R1 = Σ||Fo|-|Fc||/Σ|Fo|. b wR2 = {wΣ(|Fo|-|Fc|)2/Σw|Fo|2}}1/2. c GOF = {Σw(|Fo|-|Fc|)2/(n-p)}1/2, 
where n is the number of reflections and p is total number of parameters refined 
 
5.2 Solvento Ruthenium(II) Complexes with NSHC Ligand  
 
5.2.1 Introduction 
It is now well-recognized that the organometallic chemistry of ruthenium(II) is 
dominated by complexes with two-electron donor ligands such as phosphines 
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or N-heterocyclic carbenes and six-electron donor ligands cyclopentadienyl or 
p-cymene.134-135,288 Recent studies on the rational design of new ruthenium 
catalysts revealed that in addition to these dominating ligands, the ancillary 
ligands employed should be labile and weakly coordinated.104,232,289-292 These 
ancillary ligands can be easily replaced by stronger coordinating ones, other 
metal cores or substrates293-294 which merit them as useful starting materials 
for synthesis of other complexes and inorganic materials295-302 or generate 
coordinate vacancies for catalytic cycles303-305. One obvious strategy is to use 
solvato ruthenium complexes (donor solvent molecules such as CH3CN, DMF 
and DMSO). For example, Buchmeiser reported ionic ruthenium NHC 
complex [Ru(CF3COO)(IMes)(CH3CN)4][CF3COO]177 which is highly active 
towards UV-induced ring-opening metathesis polymerization. The 
half-sandwich ruthenium complex [RuCp(IPri)(CH3CN)2] was synthesized by 
Kirchner and co-workers which could provide several coordination and 
reaction sites by minimizing the coordination sites of inert ligands.306 In 
addition, such complexes are good precursors for other ruthenium complexes 
which target large kinase active site307 or help to understand intermediates of 
reactions305,308-310. During the course of our study on Ru(II)-NSHC complexes, 
we also serendipitously isolated Ru(II)-NSHC-solvato complexes 
[RuBr(PPh3)(N-BzBzTh)(CH3CN)3]X (X = Br (5.4), BF4 (5.5)). In this section, 
we will report the synthesis of solvate ruthenium complexes 
[RuBr(PPh3)(N-BzBzTh)(CH3CN)]X (X = Br (5.4); BF4 (5.5)) in avoiding 
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the use of silver substrates. 
 
5.2.2 Results and Discussion 
5.2.2.1 Synthesis of Complexes 5.3–5.5 
Reaction of complex 2.1 with maleic acid and sodium maleate in THF yielded 
an orange color complex 5.3 in which the acetate group was replaced by 
maleate. It is what we have expected as the strong acid with high chelating 
ability (maleic acid) may substitute actetate ligand in ruthenium precursor 2.1 
to release weak acetic acid. Further study disclosed that the reaction gave the 
mixture of starting material 2.1 and complex 5.3 in the absence of sodium 
maleate base. The coming surmise is that the maleic acid–sodium maleate 
buffer may consume acetic acid generated which pushes the chemical 
equilibrium move to the right. However, while the acid with strong chelation 
picolinic acid (HPA) was introduced, only compound Ru(PPh3)2(PA)2 (31P 
NMR (CD2Cl2): δ 37.2 ppm) was observed. In this case the strong chelating 
effect of picolinic acid may dominate. Attempts to obtain the solid state 
structure of complex 5.3 proved to be unsuccessful. Surprisingly, the 
immediate color change from orange to yellow was observed while complex 
5.3 was dissolved in acetonitrile. Further study showed that complex 5.3 
decomposed in acetonitrile to give the mixture of 
[RuBr(PPh3)(N-BzBzTh)(CH3CN)3]Br (5.4) (31P NMR CD3CN: 50.1 ppm) and 
an unknown compound (31P NMR CD3CN: 25.6 ppm). Complex 5.4 can be 
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prepared by alternative ways, i.e., direct reaction between complex 2.1 and 
maleic acid in CH3CN under reflux. Nevertheless, if the reaction was carried 
out at r.t., it gave the mixture of 5.4 and some unknown kinetic product (31P 
NMR CD3CN: 25.6, 27.4, 47.8 ppm) which can be fully converted to 
thermodynamic products upon heating (31P NMR CD3CN: 25.6 and 50.1 ppm). 
Other di-carboxyl acids such as fumaric acid and succinic acid have also been 
introduced to observe the reactivity toward 2.1. Although they both afforded 
5.4, it is formed in combination of other uncharacterized compounds. The 
results suggested that the pKa value and chelating effect of acid should have 
influence on the reaction but the detailed process is illusive. As reported by 
Kühn et al.,311 nitrile ligated transition metal complexes can be synthesized by 
three methods, i.e., oxidation of metals with nitrosonium salts of the intended 
counteranion, dehydration of aqueous salts and introduction of WCAs (silver, 
potassium and ammonium salts) to metal salts. Herein, a facile way was 
presented to synthesize this type of complex. 
Facile ion exchange of complex 5.4 with NaBF4 yielded 
[RuBr(PPh3)(N-BzBzTh)(CH3CN)3][BF4] (5.5). Complex 5.5 can also be 
synthesized from complex 2.1 or 5.3 as shown in Scheme 5.3. Complexes 
5.3–5.5 are generally stable in solid state while they decompose in solution 
especially for complex 5.3. Complex 5.3 is soluble in common organic 
solvents THF, CH2Cl2 and CHCl3. Complexes 5.4–5.5 are only slightly soluble 
in CH3CN. Complexes 5.4–5.5 were characterized by X-ray diffraction while 
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5.3 is characterized by elemental analysis and NMR spectroscopy. 
 
 
Scheme 5.2 Synthetic route of complexes 5.3–5.5 
 
5.2.2.2 Molecular Structures of Complex 5.4 and 5.5 
Complexes 5.4 and 5.5 have been crystallized and their structures 
unequivocally elucidated by single-crystal X-ray diffraction studies. (Figure 
5.2) Their selected bond lengths are listed in Table 5.3. They represent the first 
isolation of Ru(II)-NSHC complexes with coordinated solvents. Complexes 
5.4 and 5.5 only differentiate in their anions therefore only the structure of 
complex 5.4 will be discussed in detail. The cationic moiety of complex 5.4 
shows an octahedral ruthenium sphere with four different ligands, namely, 
NSHC carbene, triphenyl phosphine, bromide and acetonitrile. The axial 
direction is occupied by carbene ligand and one acetonitrile molecule and the 
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remaining ligands constitute a nearly perfect equatorial plane (mean deviation, 
0.0363 Å). As expected, phosphine is trans to bromide in avoiding of facing a 
high trans-ligand carbene. Similarly, Ru(1)-N(4) bond (2.112(3) Å) in a trans 
position relative to the NSHC is the longest one. (Ru(1)-N(2) (2.009(3) Å); 
Ru(1)-N(3) (2.027(3) Å)), indicative of its ground state destabilization. This 
Ru-N bond should be dissociatively cleaved first during any substitution 
reaction. These Ru-N bonds are in the range of reported Ru-NHC actetonitrile 
complexes.306,312 The Ru-Ccarbene bond (2.018(3) Å) is a bit longer than its 




Figure 5.2. Ortep diagrams of the cationic structure of 5.4 with 50% probalility ellipsoids 
and labelling scheme, the hydrogen atoms, solvent molecule and anion atoms were 






Table 5.3 Selected bond lengths (Å) and angles (°) for 5.4 and 5.5 
 5.4 5.5 
Ru(1)-C(1) 2.018(3) 2.016(3) 
Ru(1)-N(2) 2.009(3) 2.031(2) 
Ru(1)-N(3) 2.027(3) 2.093(3) 
Ru(1)-N(4) 2.112(3) 2.004(3) 
Ru(1)-P(1) 2.3131(9) 2.3183(9) 
Ru(1)-Br(1) 2.5737(4) 2.5784(5) 
 
5.2.3 Summary 
The acid effect to ruthenium complex 2.1 has been studied. The acid with 
different pKa value may lead to different structures. Future work will focus on 
the determining of their structures studying their reaction mechanism. In 
addition, the simple method has been provided to prepare solvato (CH3CN) 
Ru(II)-NSHC complexes avoiding the use of silver source. These complexes 
stabilized by labile nitrile ligands could be applied as good precursors for the 
synthesis of various materials and complexes. Their application on different 
organic reactions will be further explored. 
 
5.2.4 Experimental Section 
5.2.4.1 General Procedures and Materials 
All manipulations were carried out under a dry nitrogen atmosphere using 
standard Schlenk techniques. Complex 2.1 was prepared according to the 
method described in chapter 2. Other commercially available chemicals were 
purchased from Sigma-Aldrich. All solvents were freshly distilled from 
standard drying agents. 1H (500.1 MHz), 31P (202.4 MHz) and 13C (125.8 
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MHz) NMR spectra were recorded in ppm on a Bruker AMX 500 spectrometer. 
The chemical shifts (δ) are referenced to TMS for 1H and 13C{1H} and H3PO4 
(85%) for 31P{1H}. Elemental analyses were performed on a Perkin-Elmer PE 
2400 elemental analyzer. 
5.2.4.2 Synthesis of Complexes 5.3–5.5 
RuBr(COOC=CCOOH)(N-BzBzTh)(COOHC=CHCOOH)2 (5.3). A 50 mL 
flask was charged with complex 2.1 (0.0989 g, 0.1 mmol), sodium maleate 
(0.0960 g, 0.6 mmol), maleic acid (0.0345 g, 0.3 mmol) and 20 mL of THF. 
The mixture was refluxed for 6 h, after which the solvent was removed under 
vacuum. The residue was washed with Et2O (2×10 mL) and redissolved in 
CH2Cl2 (5 mL) with filtration. The orange color crystalline solid was obtained 
by diffusion of Et2O to the filtration. Yield: 0.09 g (75%). 31P NMR (CDCl3): 
25.3 (s). Anal. Calc for C62H53NO12P2RuS: C, 58.22; H, 4.18; N, 1.10. Found: 
C, 58.25; H, 4.07; N, 0.93. 
[RuBr(PPh3)(N-BzBzTh)(CH3CN)3]Br (5.4). A 50 mL flask was charged 
with complex 5.3 (0.05 g) and 20 mL of CH3CN. The mixture was refluxed for 
3 h, after which the solvent was removed under vacuum. The residue was 
washed with Et2O (2×10 mL) and redissolved in CH3CN (10 mL) with 
filtration. The yellow color crystals obtained by diffusion of Et2O to the 
filtration. Yield: 0.016 g (44%). 1H NMR (CD3CN): δ 7.81 (d, 1H, Ar-H), 
7.5-7.27 (m, 20H, Ar-H), 7.13 (d, 1H, Ar-H), 7.01 (d, 1H, Ar-H), 5.47 (m, 2H, 
CH2). 31P NMR (CD3CN): 50.1 (s). Anal. Calc for C38H35Br2N4PRuS: C, 52.36; 
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H, 4.05; N, 6.43. Found: C, 52.51; H, 4.03; N, 6.42. 
[RuBr(PPh3)(N-BzBzTh)(CH3CN)3][BF4] (5.5). A 50 mL flask was charged 
with complex 5.3 (0.02 g, 0.02 mmol), NaBF4 (0.004 g, 0.04 mmol) and 20 
mL of CH3CN. The mixture was refluxed for 3 h, after which the solvent was 
removed under vacuum. The residue was washed with Et2O (2×10 mL) and 
redissolved in CH3CN (10 mL) with filtration. The yellow color crystals 
obtained by diffusion of Et2O to the filtration. Yield: 0.016 g. (40%) 31P NMR 
(CD3CN): 50.9 (s). 
5.2.4.3 X-Ray Diffraction Studies 
Suitable crystals were mounted on quartz fibers and X-ray data were 
collected on a Bruker AXS APEX diffractometer equipped with a CCD 
detector, using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). 
The data were corrected for Lorentz and polarization effects with the 
SMART program suite and for absorption effects with SADABS. The 
crystal structures were solved by direct methods and refined by full-matrix 
least squares on F2 using the SHELXTL program package. In complex 5.5, 
the asymmetric unit contains one cation C38H35N4SPRuBr, one anion BF4 
and one solvent CH3CN. The BF4 was partially replaced by Br (10%). All 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were 
calculated in ideal geometries and refined isotropically. Selected crystal 
data for complexes 5.1b and 5.2a are summarized in Table 5.4. 
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Table 5.4 Summary of crystallographic parameters and refinement results for 
complexes 5.4 and 5.5 
 5.4 5.5 
formula C40H38Br2N5PRuS C40H38BBrF3.50N5PRuS 
fw 912.67 910.07 
cryst. Syst. Monoclinic Monoclinic 
space group Pn Pn 
a (Å) 12.0494(6) 12.029(2) 
b (Å) 11.7176(6) 11.890(2) 
c (Å) 13.8631(6) 14.013(2) 
α (°) 90 90 
β (°) 92.366(1) 91.192(3) 
γ (°) 90 90 
V (Å3) 1955.7(2) 2003.9(4) 
Z 2 2 
Dcalcd (g·cm–3) 1.550 1.508 
μ (mm–1) 2.573 1.532 
F(000) 916 919 
no. of reflns collected 13606 13730 
no. of unique reflns 8217 7574 
Rint 0.0275 0.0241 
no. of observed reflns 7574 7257 
parameters 455 501 
T (K) 100(2) 100(2) 
R1a (all data) 0.0360 0.0286 
wR2b(all data) 0.0683 0.0632 
GOFc 0.909 0.999 
Δρmax (e Å–3) 1.078 0.907 
Δρmin (e Å–3) -0.393 -0.337 
 
a R1 = Σ||Fo|-|Fc||/Σ|Fo|. b wR2 = {wΣ(|Fo|-|Fc|)2/Σw|Fo|2}}1/2. c GOF = {Σw(|Fo|-|Fc|)2/(n-p)}1/2, 
where n is the number of reflections and p is total number of parameters refined 
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Chapter 6 Formation and Crystallographic Elucidation 
of Stable [4+2]-Coordinate Nickel(II) N,S-Heterocyclic 
Carbene (NSHC) Complexes 
 
6.1 Introduction 
Encouraged by the isolation of the first stable N-heterocyclic carbene (NHC) 
by Arduengo in 1991,7 many research teams have embarked on the synthesis 
of NHC complexes and a broad range of their catalytic applications.18,313-319 A 
myriad of purpose-specific catalysts can be accessed through different 
chemical modifications of heterocyclic skeletons, N-substituents, metal atoms 
and their oxidation states, ancillary ligands and a mix of these permutations. 
An increasingly popular trend is the design of carbenes with other heteroatoms 
such as P-, N,O-, N,S- heterocyclic carbenes (PHCs, NOHCs and NSHCs, 
respectively).320 Some carbene ligands such as PHCs are stable enough to be 
isolated but the majority of others such as NOHC and NSHC are usually 
isolated in their complexed state as the free ligands are unstable and undergo a 
facile proton-catalyzed chemical equilibrium with their dimers.40,161,321-322 
Accordingly, there are emerging examples of NSHCs among metals such as 
Cu(I), Au(I), Au(III), Pd(II), Ir(I), Ru(II) that are prepared from direct or 
indirect metallation methods.28,38-39,323-325 Among the neglected metals is 
nickel, which is surprising considering that it exhibits a rich structural 
chemistry326-329 and a host of catalytic functions.330-337 Within our knowledge, 
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there is no general method reported for Ni(II) NSHC (N,S-heterocyclic 
carbene) complexes, nor is there any crystallographic structural report of such 
in the literature. 
Although Ni-NHCs are the first transition metal NHC complexes to be 
isolated from free carbene,338 their development16,339-350 lag behind 
palladium272-273,351-366 and platinum266,365,367 analogues. Moreover, the 
replacement of Pd(II) with Ni(II) is a challenging subject regarding the 
cost-saving catalysts. Thus, development of nickel chemistry stands at an 
important position. We are hence interested to extend the current commonly 
used synthetic method for Pd(II)19,58-62,341,368-370 to its congeneric and 
isoelectronic d8 Ni(II) benzothiazole carbene complexes. In this chapter, we 
will study their structural characteristics and demonstrate their catalytic 
potential by their activity in Ullmann coupling reactions. 
 
6.2 Results and Discussion 
6.2.1 Synthesis of Benzothiazolium salts 
Benzothiazolium bromide salts [(C6H4)SCHNR]X (R and X = Me and I (L7); 
Et and Br (L8)) could be obtained as light yellow powders in good yields 
(>90%) by treatment of the freshly distilled benzothiazole and appropriate 
alkyl halide at 80 °C using a solvent-free method (Scheme 6.1).58 Their 1H 
NMR spectra invariably show downfield resonances for the SCHN protons in 




Scheme 6.1. Synthesis of benzothiazolium salts L7 and L8 
 
6.2.2 Synthesis and Characterization of Ni(II) complexes 
The benzothiazolium salts are convenient synthetic precursors to carbene. This 
is exemplified by a general and one-step condensation reaction with anhydrous 
Ni(OAc)2 in dry THF which gives the corresponding neutral 
benzothiazol-2-ylidene (BzTh) Ni(II)-NSHC complexes 
trans-[NiX2(N-RBzTh)2] (R/X = Bz/Br (6.1); Me/I (6.2); Et/I (6.3); Pri/I(6.4); 
Bui/I(6.5)) in 66–84% yields (Scheme 6.2). Ni(II)-NSHC complexes are 
generally absent in the literature with a notable early example of a cationic 
mono-carbene complex prepared from oxidative addition of 
chloro-1,3-thiazole with Ni(0). In the preparation of 6.3, NaI is added to assist 
the crystallization of good quality single crystals. Complexes 6.1–6.5 are 
stable in dry air but are moisture sensitive. They are very soluble in solvents of 
high dielectric constant such as DMF and DMSO. Complex 6.1 is highly 
soluble in MeCN, CH2Cl2, THF and toluene, whereas 6.2–6.5 are moderately 
soluble in CH3CN, CH2Cl2 and THF, but insoluble in toluene. Their elemental 
analyses data are consistent with their chemical formulae. The NCHS protons 
in L1–L3 and L7–L8 (1H NMR) are absent in 6.1–6.5 upon complex 





Scheme 6.2 Syntheses of Ni(II) bis(benzothiazol-2-ylidene) complexes 6.1–6.5 
 
6.2.3 Molecular Structures of Nickel Complexes 
The 1H NMR spectra, except that of complex 6.1, show two sets of signals for 
the aliphatic protons, suggesting the coexistence of tran-anti and trans-syn 
rotamers in solutions. X-ray single-crystal crystallographic analysis of 6.1–6.5 
revealed an essentially square-planar geometry for Ni(II) (cis X–Ni–C 
89.38(7)°–90.9(3)° and trans 179.3(4)°–180°) with two NSHC ligands 
mutually trans to each other, and similar for the two halides X (Figure 6.1 and 
Table 6.1). These complexes invariably show the trans-anti conformers in the 
crystalline state which are in good agreement with their analogous Ni-NHC 
complexes, such as trans-NiCl2(Cy2Im)2 (Cy2Im = 
1,3-dicyclohexylimidazolin-2-ylidene),371 trans-NiCl2(Mes2Im)2 (Mes2Im = 
1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene),372 and 
trans-NiI2(iPr2Im)2 (iPr2Im = 1,3-diisopropylimidazolin-2-ylidene).330 The 
C3NS heterocyclic planes invariably twist out and nearly perpendicular to the 
coordination plane (dihedral angle δ >81.1°). The Ni–C bonds 
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(1.890(11)–1.910(9) Å) are similar to those in related Ni-NHC complexes, 
such as trans-NiI2(MePrIm)2 (MePrIm = 
3-methyl-1-propylimidazolin-2-ylidene) (1.899(11) Å),330 
NiBr(η3-C3H5)(Me4Im) (Me4Im = 1,3,4,5-tetramethylimidazol-2-ylidene) 
(1.907(2) Å)373 and NiI2(Me2CH2Im2)2 (Me2CH2Im2 = 
1,1’-dimethyl-3,3’-methylenediimidazoline-2,2’-diylidene) (1.909(2) Å).374 
The Ni–Br bond length in 6.1 (2.3138(3) Å) and Ni-I in 6.2–6.5 (2.4757(14) – 
2.4959(7) Å) are comparable to those reported in related Ni-NHC carbene 
complexes, such as trans-NiBr2(Cy2Im)2 (Cy2Im = 
1,3-dicyclohexylimidazol-2-ylidene) (2.3113(4) Å),313,371 trans-NiI2(MePrIm)2 
(MePrIm = 3-methyl-1-propylimidazolin-2-ylidene) (2.4952(8) Å)330 and 
trans-NiI2(PrMeIm)2 (PrMeIm = 1-propyl-3-methylbenzimidazolin-2-ylidene) 
(2.4906(4) Å).339 
 
Table 6.1 Selected bond lengths (Å) and angles (°) for 6.1–6.5 
 6.1·2toluene 6.2 6.3 
Ni(1)–X(1)a 2.3139(3) 2.490(1) 2.4883(2) 
Ni(1)–X(2) – 2.476(1) – 
Ni(1)–C(1) 1.893(2) 1.910(9) 1.895(2) 
Ni(1)–C(9)  – 1.893(8) – 
C(1)–S(1) 1.714(2) 1.73(1) 1.726(2) 
C(9)–S(2) – 1.754(9) – 
C(1)–N(1)  1.329(3) 1.31(1) 1.330(3) 
C(9)–N(2) – 1.33 (1) – 
C(1)–Ni(1)–X(1)a 90.62(7) 90.9(3) 89.61(7) 
C(9)–Ni(1)–X2) – 89.3(3) – 
S(1)–C(1)–Ni(1) 119.7(1) 122.8(5) 120.7(1) 
S(2)–C(9)–Ni(1) – 122.0(5) – 
N(1)–C(1)–Ni(1) 130.6(2) 126.9(7) 129.5(2) 
N(2)–C(9)–Ni(1) – 128.0(7) – 
S(1)–C(1)–N(1) 109.70(15) 110.3(7) 109.8(2) 
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S(2)–C(9)–N(2) – 110.0(6) – 
dihedral b 85.7 93.2/93.5 85.3 
    
 6.4 6.5  
Ni(1)–X(1)a 2.4916(2) 2.4959(7)  
Ni(1)–X(2) – –  
Ni(1)–C(1) 1.896(2) 1.89(1)  
Ni(1)–C(9)  – –  
C(1)–S(1) 1.717(3) 1.74(1)  
C(9)–S(2) – –  
C(1)–N(1) 1.333(3) 1.32(2)  
C(9)–N(2) – –  
C(1)–Ni(1)–X(1)a 90.17(7) 89.7(3)  
C(9)–Ni(1)–X2) – –  
S(1)–C(1)–Ni(1) 121.5(1) 118.1(7)  
S(2)–C(9)–Ni(1) – –  
N(1)–C(1)–Ni(1) 128.4(2) 131.8(9)  
N(2)–C(9)–Ni(1) – –  
S(1)–C(1)–N(1) 110.1(2) 110.1(9)  
S(2)–C(9)–N(2) – –  
dihedral b 88.8 81.1  
    


















Figure 6.1 ORTEP diagrams of the structures of 6.1–6.5 with 50% probability ellipsoids 
and labelling scheme, showing the Ni···H–C anagostic interactions in complexes 6.1–6.4. 
A: -x + 1, -y, -z (6.1); -x + 1, -y + 1, -z (6.3); -x + 2, -y + 2, -z (6.4); -x + 0.5, -y + 1.5, -z 
(6.5). 
 
An additional incentive for the NSHC ring to twist out of the coordination 
plane is to allow the γ-H on the N-substituent to move above and below the Ni 
center. This promotes weak anagostic M···H–C interactions, which are 
typically associated with d8 systems and believed to have considerable 
relevance to many catalytic processes.375-377 The Ni···H–C distances thus 
observed (2.63–2.98 Å) are similar or shorter (except in 6.5) than the sum of 
van der Waals radii of 2.83 Å for Ni and H (Table 6.2). This is consistently 
found in different substituents, covering benzyl (6.1), methyl (6.2), ethyl (6.3) 
and isopropyl (6.4), thus resulting in [4+2] coordination and tetragonally 
distorted octahedral-like structures of Ni(II) in the solid state. Similar 
interactions are found in some Ni(II) NHC complexes337 but not apparent in 
the others.326-329 The interaction would be most effective when the carbene 
ring plane is near-perpendicular to the coordination plane as it would place the 
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γ-H directly above or below the metal, giving pseudo-double-chelates. This is 
exemplified in 6.4 which has the shortest Ni···H–C separation (2.63 Å) when 
the two planes are nearly orthogonal (88.8°), whereas in 6.5, the longest 
separation (2.98 Å) is associated with the smallest dihedral angle (81.1°) 
(Table 6.2). These electrostatic interactions are persistent in the solutions of 
6.1–6.4 as witnessed in the downfield shift of ΔH = 0.05 – 1.58 ppm for the 
deshielding N-CH protons compared to their counterpart in the ligand 
precursor. 
 
Table 6.2 Comparison of selected structural and spectroscopic data for the anagostic C–H 
protons in 6.1–6.4 
Complex δHa (ΔδH)b (ppm) d(H···M) (Å) θ(C–H···M) (°) 
6.1 6.79 (0.36) 2.80 117 
6.2 4.82(0.11)/4.76(0.05)c 2.77/2.69 112/117 
6.3 5.54(0.38)/5.44(0.28)c 2.83 113 
6.4 7.12(1.58)/6.99(1.45)c 2.63 122 
a Measured in CDCl3. b ΔδH = δH (complex) – δH (corresponding ligand precusor). c Two 
resonances from trans-anti and trans-syn rotamers. 
 
6.2.4 Ullmann-type Coupling Reaction 
The complexes 6.1–6.5 are catalytically active towards the reductive Ullmann 
coupling378 reactions of aryl bromides under standard conditions of 1 mol % 
catalyst and 75 mol % of reducing zinc379 in an ionic liquid Bu4NBr medium 
(Table 6.3). Electron donating 4-bromotoluene and 4-bromoanisole, 
unexpectedly, give better coupling yields (26–92 %) than bromobenzene 
(14–69 %). This is at odds with other recent reports in which Pd(OAc)2 or 
Ni-NHC catalysts are used.337,380-382 It is also surprising that 
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electron-withdrawing 4-bromobenzaldehyde gives no significant product in all 
cases. Use of DMF as solvent also gives no significant product. For 
bromotoluene or bromoanisole, complexes 6.4 and 6.5 (70–92%) generally 
show better activities than 6.1–6.3 (26–48%). Complex 6.4 in particular, 
which shows the strongest H···Ni interaction, registers the highest yields of 
92% (Entry 9) and 75% (Entry 14). When the ligand precursor of 6.4 and 6.5 
viz. L2 or L3 (2%) are used with Ni(OAc)2 (1%) in an attempt to generate an 
in-situ catalytic mixture, the yields are significantly lower (43% (run 16) and 
46% (run 17)). The catalytic yields of the current system are generally 
comparable to those in the literature.85-87 For example, similar coupling of 
4-bromoanisole using the more expensive Pd/C in water and liquid CO2 in 
high pressure (6 MPa) gives a yield of 53%.381 Homocoupling of 
4-bromoanisole with 4 mol % Pd(OAc)2 with As(o-tol)3 at 100 °C affords a 
yield of 54%.382 
 
Table 6.3 Ullmann coupling reaction of aryl bromides catalyzed by 
complexes 6.1–6.5 
 
Run Catalyst Aryl halide Yield (%) 
1 6.1 bromobenzene 57 
2 6.2 bromobenzene 19 
3 6.3 bromobenzene 14 
4 6.4 bromobenzene 35 
5 6.5 bromobenzene 69 
6 6.1 4-bromotoluene 48 
7 6.2 4-bromotoluene 37 
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8 6.3 4-bromotoluene 26 
9 6.4 4-bromotoluene 92 
10 6.5 4-bromotoluene 82 
11 6.1 4-bromoanisole 43 
12 6.2 4-bromoanisole 44 
13 6.3 4-bromoanisole 46 
14 6.4 4-bromoanisole 75 
15 6.5 4-bromoanisole 70 
16 Ni(OAc)2/L2 4-bromoanisole 43 
17 Ni(OAc)2/L3 4-bromoanisole 46 
 
6.3 Summary 
There are emerging examples of Ni(II)-NHC complexes in the 
literature.16,339-350,383-386 This introduction of the NSHC series with a softer 
and substituent-less sulfur atom on the heterocyclic ring would provide a 
simple mechanism to modify the electronic and steric effect imparted by 
the carbene ligand. At present there is no evidence of sulfur coordination to 
metal. Any chemical stability or catalytic activity gained from the use of 
benzothiazolin-2-ylidene ligand is probably attributed to the π donation 
effect of sulfur that could stabilize the M-C coordinative unit.  
 
6.4 Experimental Section 
6.4.1 General Procedures and Materials 
All manipulations were carried out under a dry nitrogen atmosphere using 
standard Schlenk techniques. Ligand L1–L3 were prepared according to the 
literature method. Ni(OAc)2·4H2O was dried under vacuum at 130 °C to 
remove the water solvate. Other commercially available chemicals were 
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purchased from Sigma-Aldrich. All solvents were freshly distilled from 
standard drying agents. 1H and 13C NMR spectra were recorded on a Bruker 
ACF 300 spectrometer, and chemical shifts (δ) for 1H and 13C spectra were 
recorded in ppm relative to the residual proton of CDCl3 (1H: 7.26 ppm; 13C: 
75.48 ppm). Elemental analyses were performed on a Perkin-Elmer PE 2400 
elemental analyzer. ESI mass spectra were obtained using a Finnigan LCQ. 
The yields of C–C coupling products were determined by using Hewlett 
Packard Series 6890 GC (Santa Clara, CA, USA) coupled to a Hewlett 
Packard 5973 MS detector. 
6.4.2 Preparation of Benzothiazolium Salts and Ni(II) Complexes 
N-methylbenzothiazolium iodide (L7) 
A mixture of benzothiazole (2.71 g, 20.0 mmol) and iodomethane (3.00 g, 
21.2 mmol) was stirred at r.t. for about 24 h to yield off-white solid, which 
was collected by filtration and washed successfively with CH2Cl2 and Et2O, 
and dried in vacuum. Yield: 5.12 g (18.5 mmol, 92%). 1H NMR (300.1 
MHz, CDCl3): δ 11.96 (s, 1H, NCH), 8.26 (d, 1H, 3JHH = 8.10 Hz, Ar-H), 
8.06 (d, 1H, 3JHH = 8.70 Hz, Ar–H), 7.95 (t, 1H, Ar–H), 7.88 (t, 1H, 
Ar–H), 4.71 (s, 3H, CH3). 13C NMR (75.48 MHz, CDCl3): δ 165.4 (NCS), 
131.2, 130.2, 125.3, 116.9 (Ar–C), 41.0 (CH3). MS (ESI, positive mode) 
m/z (%): 150.1 (100) [M – I]+. Anal. Calc for C8H8INS: C, 34.67; H, 2.91; 
N, 5.05. Found: C, 34.82; H, 2.99; N, 5.01. 
N-ethylbenzothiazolium bromide (L8) 
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A mixture of benzothiazole (2.71 g, 20.0 mmol) and bromoethane (2.50 g, 
22.9 mmol) was stirred at 80 °C overnight to yield a large amount of light 
yellow crude product, which was collected and washed with diethyl ether. 
The solid was then washed with dichloromethane to afford white solid, and 
dried in vacuum. Yield: 3.86 g (18.6 mmol, 93%). 1H NMR (300.1 MHz, 
CDCl3): δ 11.87 (s, 1H, NCH), 8.45 (d, 1H, 3JHH = 8.10 Hz, Ar–H), 8.16 
(d, 1H, 3JHH = 8.40 Hz, Ar–H), 7.86 (t, 1H, Ar–H), 7.76 (t, 1H, Ar–H), 
5.16 (m, 2H, CH2), 1.73 (t, 3H, CH3). 13C NMR (75.48 MHz, CDCl3): δ 
165.1 (NCS), 140.6, 132.1, 130.8, 129.7, 126.0, 117.2 (Ar–C), 49.6 
(CH2CH3), 15.6 (CH2CH3). MS (ESI, positive mode) m/z (%): 164.1 (100) 
[M – Br]+. Anal. Calc for C9H10BrNS: C, 44.27; H, 4.13; N, 5.74. Found: C, 
44.34; H, 4.11; N, 5.68. 
Dibromobis(N-benzylbenzothiazolin-2-ylidene)nickel(II) (6.1) 
A mixture of Ni(OAc)2 (0.088 g, 0.5 mmol) and L1 (0.306 g, 1 mmol) was 
stirred under vacuum at 50 °C for 1 h. THF (20 mL) was then added and the 
suspension refluxed overnight. After cooling, the solvent was removed 
under vacuum, leaving a wine-red residue. The solid was washed with 
hexane (20 mL) and extracted with toluene (20 mL). Red crystals were 
formed when the solution extract was cooled to –20 °C for several days. 
Yield: 0.28 g (0.42 mmol, 84%). 1H NMR (300 MHz, CDCl3): δ 7.74 (b, 
1H, Ar-H), 7.53 (b, 3H, Ar–H), 7.33 (b, 4H, Ar–H), 7.38 (b, 1H, Ar-H), 
6.79 (s, 2H, CH2). 13C NMR (75.48 MHz, CDCl3): δ 134.2 127.7, 
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126.2 ,124.4, 121.7, 114.4, (Ar–C), 59.2 (CH2). Anal. Calc for 
C28H22Br2N2NiS2 (6·0.2C6H5CH3).: C, 50.26; H, 3.31; N, 4.19. Found: C, 
51.15; H, 3.54; N, 4.13  
General procedures for the preparation of 
trans-diiodobis(benzothiazolin-2-ylidene)nickel(II) complexes (6.2–6.5) 
A mixture of Ni(OAc)2 (0.088 g, 0.5 mmol) and ligand L2–L3 and L7–L8 
(1 mmol) was stirred under vacuum at 50 °C for 1 h (for ligand L8, NaI 
(0.30 g, 2mmol) was added). THF was then added and the suspension 
refluxed overnight. After cooling, the solvent was removed under vacuum, 
leaving the wine-red residue, which was re-dissolved in 20 mL of CH2Cl2 
and was filtered. The solution was mixed with Et2O (5 mL) and cooled to 
–20 °C to yield red crystals of 6.2–6.5 in one week. 
Diiodobis(N-methylbenzothiazolin-2-ylidene)nickel(II) (6.2) 
Yield: 0.22 g (0.36 mmol, 72%). 1H NMR (300 MHz, CDCl3): δ 7.75 (d, 
1H, 3JHH = 7.80 Hz, Ar–H), 7.60 (d, 1H, 3JHH = 8.10Hz, Ar–H), 7.75 (t, 
1H, Ar–H), 7.35 (t, 1H, Ar–H), 4.82 (m, CH3), 4.76 (m, CH3). 13C NMR 
(75.48 MHz, CDCl3): δ 144.7, 126.2, 124.2, 121.6, 112.6 (Ar–C), 42.1 
(CH3). Anal. Calc for C16H14I2N2NiS2: C, 31.46; H, 2.31; N, 4.59. Found: C, 
31.27; H, 2.36; N, 4.49. 
Diiodobis(N-ethylbenzothiazolin-2-ylidene)nickel(II) (6.3) 
Yield: 0.21 g (0.33 mmol, 66%). 1H NMR (300 MHz, CDCl3): δ 7.79 (d, 
1H, 3JHH = 8.10 Hz, Ar–H), 7.62 (d, 1H, 3JHH = 7.20 Hz, Ar–H), 7.44 (t, 
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1H, Ar–H), 7.33 (t, 1H, Ar–H), 5.54 (m, CH2), 5.44 (m, CH2), 1.95 (t, 3H, 
CH3). 13C NMR (75.48 MHz, CDCl3): δ 126.0, 124.1, 121.8, 113.1, 112.9 
(Ar–C), 50.8 (CH2CH3), 12.9 (CH2CH3). Anal. Calc for C18H18I2N2NiS2: C, 
33.83; H, 2.84; N, 4.38. Found: C, 33.68; H, 2.84; N, 4.28. 
Diiodobis(N-isopropylbenzothiazolin-2-ylidene)nickel(II) (6.4) 
Yield: 0.28 g (0.28 mmol, 67%). 1H NMR (300 MHz, CDCl3): δ 7.79 (d, 
1H, 3JHH = 8.10 Hz, Ar–H), 7.70 (d, 1H, 3JHH = 7.80 Hz, Ar–H), 7.38 (t, 
1H, Ar–H), 7.28 (t, 1H, Ar–H), 7.12 (m, CH), 6,99 (m, CH), 2.09 (d, CH3), 
1.99 (d, CH3). 13C NMR (75.48 MHz, CDCl3): δ 142.7, 139.2, 125.5, 123.9, 
122.0, 115.2 (Ar–C), 62.2 (CH(CH3)2), 19.9 (CH(CH3)2). Anal. Calc for 
C20H22I2N2NiS2: C, 36.01; H, 3.32; N, 4.20. Found: C, 35.75; H, 3.38; N, 
4.09.  
Diiodobis(N-isobutylbenzothiazolin-2-ylidene)nickel(II) (6.5) 
Yield: 0.31 g (0.33 mmol, 74%). 1H NMR (300 MHz, CDCl3): δ 7.74 (d, 1H, 
Ar–H), 7.60 (d, 1H, Ar–H), 7.42 (t, 1H, Ar–H), 7.32 (t, 1H, Ar–H), 5.05 (d, 
CH2), 4.94 (d, CH2), 3.85 (m, CH2), 3.42 (m, CH2), 1.27 (d, CH3), 1.21 (d, 
CH3). 13C NMR (75.48 MHz, CDCl3): δ 145.4, 137.5, 125.8, 124.0, 121.6, 
115.6 (Ar–C), 62.0 (CH2CH(CH3)2), 28.2 (CH2CH(CH3)2), 21.0 
(CH2CH(CH3)2). Anal. Calc for C22H26I2N2NiS2: C, 38.01; H, 3.77; N, 4.03. 
Found: C, 37.98; H, 3.76; N, 3.96. 
6.4.3 General Procedure for Ullmann Coupling Reaction 
A mixture of zinc powder (0.049 g, 0.75 mmol) and [Bu4N]Br (1 g, excess) 
135 
was dried in vacuum at 80 °C for 2 h. The corresponding nickel(II) carbene 
complex catalyst (0.01 mmol) was added, followed by the injection of liquid 
aryl halides (1 mmol). The mixture was stirred at 115 °C for 24 h. The reaction 
was quenched with deionized water and the biaryl product extracted with Et2O 
and dried with MgSO4. The volatiles were removed under vacuum to give a 
crude product which was analyzed by GC-Mass chromatography. 
6.4.4 X-Ray Crystallography 
Suitable crystals were mounted on quartz fibers and X-ray data were collected 
on a Bruker AXS APEX diffractometer equipped with a CCD detector, using 
graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The data were 
corrected for Lorentz and polarization effects with the SMART program suite 
and for absorption effects with SADABS. The crystal structures were solved 
by direct methods and refined by full-matrix least squares on F2 using the 
SHELXTL program package. For 6.1·2C6H5CH3, the toluene solvate shows 
two-fold disorder and was refined with a disorder model. The occupancy 
factors for the two disordered parts were refined with 0.52:0.48. All 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were 
calculated in ideal geometries and refined isotropically. Selected crystal data 
for complexes 6.1–6.5 are summarized in Table 6.4. 
 
Table 6.4 Summary of crystallographic parameters and refinement results for  
complexes 6.1–6.5 
 6.1·2toluene 6.2 6.3 
formula  C42H38Br2N2NiS2 C16H14I2N2NiS2 C18H18I2N2NiS2 
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fw 853.39 610.92 638.97 
cryst. Syst. triclinic orthorhombic monoclinic 
space group Pī Pna2(1) P21/n  
a (Å) 8.3327(5) 15.503(2) 9.0231(5) 
b (Å) 8.7543(5) 10.986(2) 10.4549(5) 
c (Å) 14.4928(9) 11.369(2) 11.1487(6) 
α (°) 98.214 (1)   
β (°) 104.950(1) 93.817(1) 90.5030(10) 
γ (°) 102.293(1)   
Dcalcd (g·cm–3) 1.452 2.096  2.022  
V (Å3) 975.9(1) 1936.2(5) 1049.4(1) 
Z 1  4  2 
μ (mm–1) 2.683 4.406 4.069  
F(000) 434 1160 612 
no. of reflections collected 12903 13192 7234 
no. of unique reflections 4481 4084 2404 
Rint 0.0262 0.0453 0.0208 
no. of observed reflections 3640 4084 2270 
parameters 265 210 116  
Ra 0.0366 0.0485 0.0218 
wRb 0.0906 0.1085 0.0536 
GOFc 1.043 1.017 1.043 
Δρmax (e Å–3) 0.689  1.040  0.670  
Δρmin (e Å–3) –0.264  –0.424 –0.884  
    
 6.4 6.5  
formula  C20H22I2N2NiS2 C22H26I2N2NiS2  
fw 667.03 695.08  
cryst. Syst. monoclinic monoclinic  
space group P21/ n  C2/c  
a (Å) 8.4018(5) 17.355(2)  
b (Å) 12.2872(7) 9.9210(9)  
c (Å) 11.0743(6) 14.951 (1)  
α (°)    
β (°) 93.931(2)   
γ (°)    
Dcalcd (g·cm–3) 1.938  1.798  
V (Å3) 1143.2 (1) 2568.2(4)  
Z 2  4  
μ (mm–1) 3.740  3.333  
F(000) 644 1352  
no. of reflections collected 14493 7236  
no. of unique reflections 2612 2264  
Rint 0.0284 0.0318  
137 
no. of observed reflections 2522 2126  
parameters 126 135  
Ra 0.0263 0.0788  
wRb 0.0573 0.2037  
GOFc 1.103 1.264  
Δρmax (e Å–3) 0.870  3.792  
Δρmin (e Å–3) –0.428 –0.904  
    
a R1 = Σ||Fo|-|Fc||/Σ|Fo|. b wR2 = {wΣ(|Fo|-|Fc|)2/Σw|Fo|2}}1/2. c GOF = {Σw(|Fo|-|Fc|)2/(n-p)}1/2, where n 
is the number of reflections and p is total number of parameters refined. 
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Appl. Organomet. Chem. 2006, 20, 322. 
 (156) Poyatos, M.; Maisse-François, A.; Bellemin-Laponnaz, S.; Peris, 
E.; Gade, L. H. J. Organomet. Chem. 2006, 691, 2713. 
 (157) Mitchell, R. W.; Spencer, A.; Wilkinson, G. J. Chem. Soc., Dalton 
Trans. 1973, 846. 
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